US20030195553A1 - System and method for retaining vaso-occlusive devices within an aneurysm - Google Patents

System and method for retaining vaso-occlusive devices within an aneurysm Download PDF

Info

Publication number
US20030195553A1
US20030195553A1 US10/121,980 US12198002A US2003195553A1 US 20030195553 A1 US20030195553 A1 US 20030195553A1 US 12198002 A US12198002 A US 12198002A US 2003195553 A1 US2003195553 A1 US 2003195553A1
Authority
US
United States
Prior art keywords
mesh
vaso
aneurysmal
aneurysm
occlusive device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/121,980
Inventor
Michael Wallace
Joseph Eder
Brent Gerberding
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Scimed Inc
Stryker European Operations Holdings LLC
Original Assignee
Scimed Life Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scimed Life Systems Inc filed Critical Scimed Life Systems Inc
Priority to US10/121,980 priority Critical patent/US20030195553A1/en
Assigned to TARGET THERAPEUTICS, INC. reassignment TARGET THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: EDER, JOSEPH, GERBERDING, BRENT, WALLACE, MICHAEL
Priority to JP2003583267A priority patent/JP4414767B2/en
Priority to ES03721607T priority patent/ES2331567T3/en
Priority to CA2481224A priority patent/CA2481224C/en
Priority to DE60328765T priority patent/DE60328765D1/en
Priority to PCT/US2003/010997 priority patent/WO2003086240A1/en
Priority to EP03721607A priority patent/EP1494619B1/en
Priority to AT03721607T priority patent/ATE439092T1/en
Priority to AU2003224913A priority patent/AU2003224913A1/en
Publication of US20030195553A1 publication Critical patent/US20030195553A1/en
Priority to US11/617,293 priority patent/US20070106311A1/en
Assigned to BOSTON SCIENTIFIC SCIMED, INC. (FORMERLY SCIMED LIFE SYSTEMS, INC.) reassignment BOSTON SCIENTIFIC SCIMED, INC. (FORMERLY SCIMED LIFE SYSTEMS, INC.) CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE PREVIOUSLY RECORDED ON REEL 012812 FRAME 0175. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Assignors: EDER, JOSEPH, GERBERDING, BRENT, WALLACE, MICHAEL
Priority to US13/091,608 priority patent/US9314326B2/en
Assigned to STRYKER NV OPERATIONS LIMITED, STRYKER CORPORATION reassignment STRYKER NV OPERATIONS LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BOSTON SCIENTIFIC SCIMED, INC.
Assigned to STRYKER MEDTECH LIMITED reassignment STRYKER MEDTECH LIMITED NUNC PRO TUNC ASSIGNMENT (SEE DOCUMENT FOR DETAILS). Assignors: STRYKER NV OPERATIONS LIMITED
Assigned to STRYKER EUROPEAN HOLDINGS I, LLC reassignment STRYKER EUROPEAN HOLDINGS I, LLC NUNC PRO TUNC ASSIGNMENT (SEE DOCUMENT FOR DETAILS). Assignors: STRYKER MEDTECH LIMITED
Assigned to STRYKER CORPORATION, STRYKER NV OPERATIONS LIMITED reassignment STRYKER CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BOSTON SCIENTIFIC SCIMED, INC.
Assigned to STRYKER MEDTECH LIMITED reassignment STRYKER MEDTECH LIMITED CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT SERIAL # 09/905,670 AND 07/092,079 PREVIOUSLY RECORDED AT REEL: 037153 FRAME: 0034. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT. Assignors: STRYKER NV OPERATIONS LIMITED
Assigned to STRYKER EUROPEAN HOLDINGS I, LLC reassignment STRYKER EUROPEAN HOLDINGS I, LLC CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT LISTED SERIAL NOS. 09/905,670 AND 07/092,079 PREVIOUSLY RECORDED AT REEL: 037153 FRAME: 0241. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE DATE 9/29/2014. Assignors: STRYKER MEDTECH LIMITED
Assigned to STRYKER EUROPEAN HOLDINGS III, LLC reassignment STRYKER EUROPEAN HOLDINGS III, LLC NUNC PRO TUNC ASSIGNMENT (SEE DOCUMENT FOR DETAILS). Assignors: STRYKER EUROPEAN HOLDINGS I, LLC
Assigned to STRYKER EUROPEAN OPERATIONS HOLDINGS LLC reassignment STRYKER EUROPEAN OPERATIONS HOLDINGS LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: STRYKER EUROPEAN HOLDINGS III, LLC
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12168Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
    • A61B17/12172Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • A61B2017/12054Details concerning the detachment of the occluding device from the introduction device
    • A61B2017/12063Details concerning the detachment of the occluding device from the introduction device electrolytically detachable

Definitions

  • the present invention relates generally to vaso-occlusion, and more particularly to systems and methods for retaining vaso-occlusive devices within an aneurysm.
  • occlusive devices are useful in filling vascular or other body spaces.
  • Some body spaces, such as vascular aneurysms, are formed due to a weakening in the wall of an artery. Often these aneurysms are the site of internal bleeding and stroke.
  • embolic agents are known to be, at least ideally, suitable for treatment of these anomalies. These treatments are commonly known as “artificial vasoocclusion.”
  • vaso-occlusive coils Implantable metal coils that are useful as artificial occlusion devices in vasculature lumens or aneurysms are herein referred to as “vaso-occlusive coils.”
  • Vaso-occlusive coils are generally constructed of a wire, usually made of a metal or metal alloy that is wound to a helix. The vaso-occlusive coil assumes an irregular shape upon discharge of the device from the distal end of the catheter.
  • a variety of vaso-occlusive coils are known. For instance, U.S. Pat. No.
  • the coils may be used for small vessel sites, e.g., 0.5-6 mm in diameter.
  • the coils themselves are described as being between 0.010 and 0.030 inches in diameter.
  • the length of the coil wire is typically 15 to 20 times the diameter of the vessel to be occluded.
  • the wire used to make up the coils may be, for instance, 0.002 to 0.006 inches in diameter.
  • Tungsten, platinum, and gold threads or wires are said to be preferred.
  • vaso-occlusive coils In addition to the various types of space filling mechanisms and geometries of vaso-occlusive coils, other particularized features of coil designs, such as mechanisms for delivering vaso-occlusive coils through delivery catheters and implanting them in a desired occlusion site, have also been described.
  • the examples of categories of vaso-occlusive coils based upon their delivery mechanisms include pushable coils, mechanically detachable coils, and electrolytically detachable coils.
  • Pushable coils are commonly provided in a cartridge and are pushed or “plunged” from the cartridge into a delivery catheter lumen. A pusher advances the pushable coil through and out of the delivery catheter lumen and into the site for occlusion.
  • Mechanically detachable vaso-occlusive coils are typically integrated with a pusher rod and are mechanically detached from the distal end of that pusher after exiting a delivery catheter. Examples of such mechanically detachable vaso-occlusive coils are found in U.S. Pat. No. 5,261,916 to Engelson or U.S. Pat. No. 5,250,071 to Palermo.
  • aneurysms present a particularly acute medical risk due to the dangers of potential rupture of the thin wall inherent in such aneurysms. Occlusion of aneurysms by use of vaso-occlusive coils without occluding the adjacent artery is a special challenge and is a desirable method of reducing such risk of rupture.
  • These vaso-occlusive devices are typically placed in an aneurysm in a manner described in U.S. Pat. No. 4,739,768 issued to Engelson.
  • a microcatheter is initially steered into or adjacent to the entrance of an aneurysm, typically aided by the use of a steerable guidewire. The wire is then withdrawn from the microcatheter lumen and replaced by the vaso-occlusive coil. The vaso-occlusive coil is advanced through and out of the microcatheter, desirably being completely delivered into the aneurysm.
  • Aneurysm commonly known as a “wide neck aneurysm,” is known to present particular difficulty in the placement and retention of vaso-occlusive coils, because vaso-occlusive coils lacking substantial secondary shape strength may be difficult to maintain in position within an aneurysm no matter how skillfully they are placed.
  • Wide neck aneurysms are herein referred to as aneurysms of vessel walls having a neck or “entrance zone” from the adjacent vessel, wherein the entrance zone has a diameter that either: (1) is at least 80% of the largest diameter of the aneurysm; or (2) is clinically observed to be too wide effectively to retain vaso-occlusive coils that are deployed using the techniques discussed above.
  • U.S. Pat. No. 6,168,622 which describes a vaso-occlusive device with a secondary shape having a bulbous body portion and an anchor.
  • the bulbous body portion is deployed within the aneurysm while the anchor is set just outside of the aneurysm, covering the aneurysm's neck or entrance zone.
  • the device is integrally formed from a tube—clamped at both ends—of braided Nickel-Titanium (NiTi) wires.
  • NiTi Nickel-Titanium
  • vaso-occlusive coils it may still be desirable to deploy vaso-occlusive coils with such a device, but the bulbous body of the vaso-occlusive device does not provide much space within the aneurysm to allow for insertion and deployment of the coils.
  • the present invention is directed to systems and methods for occluding an aneurysm having an aneurysmal neck and an aneurysmal inner wall.
  • a device in accordance with the present invention includes a mesh-like structure that may be integrally composed of a shape-memory alloy such as NiTi.
  • the device may be deployed within the aneurysm through the aneurysmal neck.
  • the device may be configured to be in a deployed state and an undeployed state, and may be configured to transition from the undeployed state to the deployed state by exposure to a higher temperature and/or by being released from a compressive force.
  • the device may function to retain finer vaso-occlusive devices such as vaso-occlusive coils and/or embolic liquids. Furthermore, the device itself may function as a vaso-occlusive device. The device may be delivered to the aneurysm by, e.g., a catheter.
  • At least one of the proximal and distal ends of the mesh-like structure is configured to be inserted through the aneurysmal neck when in an undeployed state, and configured to flare open and expand against at least a portion of the aneurysmal inner wall when in a deployed state. Having a flared open end may advantageously allow the device to conform to the shape of the aneurysm.
  • the distal end of the mesh-like structure may be configured to be inserted through the aneurysmal neck when in an undeployed state and configured to expand into a retainer against at least a portion of the aneurysmal inner wall when in a deployed state.
  • the proximal end may be configured to expand into an anchor just outside of the aneurysm to secure the mesh-like structure in position.
  • FIG. 1 is an illustration of a vaso-occlusive device constructed in accordance with a preferred embodiment of the present inventions, wherein the vaso-occlusive device is shown fully deployed within an aneurysm;
  • FIGS. 2 ( a ) and 2 ( b ) illustrate one preferred method of manufacturing the vaso-occlusive device of FIG. 1 in accordance with the present inventions
  • FIG. 3 is an illustration of another vaso-occlusive device constructed in accordance with a preferred embodiment of the present inventions, wherein the vaso-occlusive device is shown fully deployed within an aneurysm;
  • FIG. 4 illustrates one preferred method of manufacturing the vaso-occlusive device of FIG. 3 in accordance with the present inventions
  • FIG. 5 is an illustration of still another vaso-occlusive device constructed in accordance with a preferred embodiment of the present inventions, wherein the vaso-occlusive device is shown fully deployed within an aneurysm;
  • FIG. 6 illustrates one preferred method of manufacturing the vaso-occlusive device of FIG. 5 in accordance with the present inventions
  • FIG. 7 is an illustration of still another vaso-occlusive device constructed in accordance with a preferred embodiment of the present inventions, wherein the vaso-occlusive device is shown fully deployed within an aneurysm;
  • FIG. 8 illustrates one preferred method of manufacturing the vaso-occlusive device of FIG. 7 in accordance with the present inventions
  • FIGS. 9 ( a )-( c ) illustrate a preferred method of delivering and deploying the vaso-occlusive device of FIG. 1 into the aneurysm;
  • FIGS. 10 ( a )-( d ) illustrate a preferred method of delivering and deploying the vaso-occlusive device of FIG. 7 into the aneurysm
  • FIGS. 11 ( a )-( c ) illustrate a preferred method of delivering and deploying the vaso-occlusive device of FIG. 5 into the aneurysm.
  • a vaso-occlusive element 10 constructed in accordance with a preferred embodiment of the present invention is shown completely deployed within an aneurysm 40 of a blood vessel 60 .
  • the aneurysm 40 is shown with an oppositely disposed neck 70 and dome 45 .
  • the vaso-occlusive element 10 When deployed in its secondary shape, i.e., its deployed shape, the vaso-occlusive element 10 generally includes a central tubular element 15 and proximal 20 and distal 30 ends that are flared open into “umbrella” shapes. As illustrated, the flared opened ends 20 / 30 advantageously conform to the shape of the aneurysm 40 .
  • the diameter of the proximal end 20 of the vaso-occlusive element 10 is larger than the neck 70 , and thus the proximal end 20 may completely cover the neck 70 .
  • the vaso-occlusive element 10 is manufactured from a relatively dense braid.
  • the proximal end 20 may densely cover the neck 70 and function as a retainer.
  • finer vaso-occlusive devices such as vaso-occlusive coils or embolic liquids, may effectively be retained within the aneurysm 40 , or at the least, the likelihood of these devices migrating out from the aneurysm 40 is minimized.
  • the relatively dense coverage of the proximal end 20 allows the vaso-occlusive element 10 itself to function as a vaso-occlusive device.
  • the flared open distal end 30 is placed adjacent the dome 45 of the aneurysm 40 and allows the element 10 to safely conform to the shape of the dome 45 .
  • the element 10 may conform to a large variety of shapes and sizes of aneurysms 40 since the element 10 need only be secured within the aneurysm 40 by conforming the flared open distal end 30 to the dome 45 .
  • a braided tubular element 1 is constructed by braiding multiple fine wires 2 together.
  • the tubular element 1 may also be formed of wires with varying diameters braided together. It may be desirable to use a larger number of wires 2 when forming the tubular element 1 , resulting in a relatively dense braid, which provides denser coverage within the aneurysm 40 .
  • the tubular element 1 may be radiopaque.
  • One method involves braiding a radiopaque fiber, such as platinum, Pt, or gold, Au, into the tubular element 1 .
  • Another method involves plating or coating the tubular element 1 with radiopaque material. Additionally, one or more radiopaque markers may be added to the tubular element 1 .
  • the wires 2 are made from a shape memory alloy, which can be of any type, but preferably is a “one way” trainable shape memory alloy.
  • a preferable shape memory alloy for forming the braided tubular element 1 is Nickel-Titanium (NiTi)—e.g., 144 strands of 0.001′′ NiTi wires.
  • NiTi Nickel-Titanium
  • Shape memory alloys comprise a unique class of metal alloys that, once trained, are configured to “remember” a preselected shape, i.e., deployed shape, and can return to the preselected shape even if subsequently reshaped.
  • the shape memory alloy is molded and heated at or above a training, or austenite, temperature to place the shape memory alloy in an austenite phase.
  • the shape memory alloy is formed in the first preselected shape and then, once formed, is permitted to cool to a martensite finish temperature, whereupon the shape memory alloy enters a martensite phase.
  • the martensite finish temperature can be any temperature that is less than the training temperature.
  • the shape memory alloy has been trained to “remember” the first preselected shape. While in the martensite phase, the alloy is in a soft state and is formed into a second preselected shape, e.g., an undeployed shape.
  • the shape memory alloy in the martensite phase is configured to maintain the second preselected shape and, if subsequently reheated to an activation temperature, automatically returns to the first preselected shape.
  • the activation temperature can comprise any temperature that is greater than the martensite finish temperature and generally approximately equals the training temperature.
  • the shape memory alloy is configured to maintain the first preselected shape irrespective of temperature.
  • the training, martensite finishing, and activation temperatures for a shape memory alloy are adjustable, depending on the composition. For example, a slight extra amount of Nickel added to a NiTi alloy composition can change the training temperature from 0° C. to 100° C.
  • the vaso-occlusive device 10 described above is delivered to the aneurysm 40 via a delivery catheter.
  • the catheter delivers the device 10 to the aneurysm 40 and during the delivery, the device 10 maintains an undeployed shape, e.g., the original tubular shape—methods of delivery will be described in more detail below.
  • the device 10 When the device 10 is deployed, the device 10 expands into its deployed shape, e.g., having flared open proximal and distal ends 20 / 30 , as shown in FIG. 1.
  • Using a shape memory alloy to form the device 10 provides for alternative methods of expanding the device 10 into its deployed shape within the aneurysm 40 .
  • One method involves configuring the device 10 to self-expand within the aneurysm 40 when deployed and exposed to the temperature of the aneurysm 40 .
  • the training and activation temperatures are adjusted to be at, or just below, the temperature of the aneurysm, which is approximately 37° Celsius—the human body temperature.
  • the martensite temperature is adjusted to be at a lower temperature. With these temperatures set, the device 10 is heated to, or above the training temperature—austenite phase—and shaped into its desired deployed shape, as described above.
  • the temperature is lowered to, or below, the martensite finish temperature—martensite phase—and shaped into its desired undeployed shape.
  • the device 10 is then placed inside the catheter as will be described below.
  • the catheter can be constructed of a material that insulates the device 10 from the outside environment and maintains the temperature of the device 10 below the activation temperature.
  • the device 10 does not expand into its deployed shape within the catheter.
  • the temperature of the device will rise at or above the activation temperature, and the device 10 will expand into its deployed shape. Because the alloy is preferably “one way” trained, the device 10 will then be configured to maintain the deployed shape irrespective of the temperature, as described above.
  • An alternative method for expanding the device 10 into its deployed shape within the aneurysm utilizes the super-elastic characteristic of shape memory alloys. After the device 10 is configured to maintain its deployed shape irrespective of the temperature, as described above, the device 10 is then maintained in its austenite phase. When the device 10 is in its austenite phase, the device 10 is super-elastic, i.e., the device 10 may be deformed to a certain degree and still be able to return to its deployed shape. The device 10 is then placed within the catheter as will be described below, with the inner wall of the catheter compressing the device 10 into its undeployed shape. When the device 10 is released out of the catheter into the aneurysm 40 , the uncompressed device 10 automatically expands into its deployed shape because of its super-elasticity.
  • Forming the deployed shape shown in FIG. 1 is achieved by using two mandrels 85 , each having a cylindrical portion 90 and an umbrella dome-shaped mold 85 , as illustrated in FIG. 2( a ).
  • two mandrels 85 each having a cylindrical portion 90 and an umbrella dome-shaped mold 85 , as illustrated in FIG. 2( a ).
  • each end is placed over the cylindrical portion 90 of a mandrel 85 and compressed against the dome 85 , causing the ends to conform to the shape of the dome 85 and flare open.
  • the assembly of the two mandrels 80 and the element 1 is then heated at or above the training temperature to place the element 1 in the austenite phase. The assembly is maintained at that temperature until the deployed shape has been formed.
  • the assembly is cooled to, or below, the martensite finishing temperature to place the element 1 in the martensite phase.
  • the mandrels 80 are removed from the element 1 , and the element 1 is formed into an undeployed shape, e.g., the original tubular shape. This may be achieved by placing the element 1 over a cylindrical mandrel 95 and compressing the flared ends to conform to the shape of the cylindrical mandrel 95 , as shown in FIG. 2 b .
  • the element 1 may be reheated to the activation temperature, causing the element 1 to return to the deployed shape. Once the deployed shape has been recovered, the element 1 is configured to maintain the deployed shape irrespective of temperature.
  • FIG. 3 another vaso-occlusive element 110 constructed in accordance with a preferred embodiment of the present invention is shown completely deployed within the aneurysm 40 .
  • the vaso-occlusive element 110 when deployed, generally includes a central tubular element 115 and a flared distal end 130 .
  • the vaso-occlusive element 110 further includes a proximal end 120 shaped as a flattened disk, which functions as a retainer.
  • the proximal end 130 has a diameter larger than the diameter of the neck 70 , and thus completely covers the entrance zone 150 .
  • the flattened disk 130 has a layer of braided wires on both sides, and thus may advantageously provide two layers of braided wires to cover the entrance zone 150 instead of one layer with the flared open proximal end 20 shown in FIG. 1.
  • the flared open distal end 130 is placed adjacent the dome 45 of the aneurysm 40 and allows the element 110 to safely conform to the shape of the dome 45 .
  • FIG. 4 one preferred method of manufacturing the vaso-occlusive device 110 shown in FIG. 3 will now be described.
  • a braided tubular element 1 is first constructed. Forming the deployed shape is achieved by using one of the mandrels 85 shown in FIG. 2( a ) and the cylindrical mandrel shown in FIG. 2( b ), as illustrated in FIG. 4.
  • the distal end is placed over the cylindrical portion 90 of the mandrel 85 with the dome 80 and compressed against the dome 80 , causing the distal end to flare open.
  • the proximal end is placed on the cylindrical mandrel 95 .
  • the proximal tip and a portion of the central tubular portion 115 are then compressed together along the axis of the cylindrical mandrel 95 . This causes the proximal end to expand into a flattened disk 120 .
  • the assembly of the two mandrels 80 / 95 and the element 1 is then heated at or above the training temperature to place the element 1 in the austenite phase.
  • the assembly is maintained at that temperature until the deployed shape 110 has been formed.
  • the assembly is cooled to, or below, the martensite finishing temperature to place the element 110 in the martensite phase.
  • the mandrels 80 / 95 are removed from the element 110 , and the element 110 is formed into an undeployed shape, e.g., the original tubular shape 1 . This is achieved by placing the element 110 over the cylindrical mandrel 95 and compressing the flared open end and flattened disk to conform to the shape of the cylindrical mandrel 95 , as shown in FIG.
  • the element 1 is configured to expand into its deployed shape upon exposure to a higher temperature, then the element 1 may be placed within a delivery catheter in preparation for deployment, as described above. Alternatively, if the element 110 is configured to expand upon being released by a compressive force, then the element 1 is reheated to, or above, the activation temperature, causing the element 1 to return to the deployed shape 110 and to be configured to maintain the deployed shape 110 irrespective of temperature.
  • FIG. 5 another vaso-occlusive element 210 constructed in accordance with a preferred embodiment of the present invention is shown deployed within the aneurysm 40 .
  • the element 210 When in a deployed shape, the element 210 generally includes a central portion 215 and a distal end flared open into a “cup” shape 230 . Alternatively, the distal end may be flared open into a “cone” shape.
  • the vaso-occlusive element 210 further includes a proximal end 220 shaped as a flattened disk. The proximal end 220 has a diameter larger than the diameter of the neck 70 .
  • the cup shaped distal end 230 may retain fine vaso-occlusive devices such as vaso-occlusive coils and embolic liquids.
  • a braided tubular element 1 is first constructed. Forming the deployed shape is achieved by using a mandrel 280 having a cup shaped dome 285 facing outward coupled to a cylindrical portion 290 and a cylindrical mandrel 95 . To form the cup shape, the distal end of the element 1 is placed over the cylindrical portion 290 of the mandrel 280 having the dome 285 and compressed against the dome 285 , causing the distal end to flare open into a cup shape. To form the flattened disk, the proximal end is placed over the cylindrical mandrel 95 . The proximal tip and a portion of the central tubular portion 215 are then compressed together along the axis of the cylindrical mandrel 95 . This causes the proximal end to expand into a flattened disk 220 .
  • the assembly of the two mandrels 280 / 95 and the element 1 is then heated at or above the training temperature to place the element 1 in the austenite phase.
  • the assembly is maintained at that temperature until the deployed shape 210 has been formed.
  • the assembly is cooled to, or below, the martensite finishing temperature to place the element 210 in the martensite phase.
  • the mandrels 280 / 95 are removed from the element 210 , and the element 210 is formed into an undeployed shape, e.g., the original tubular shape 1 .
  • FIG. 7 another vaso-occlusive element 310 constructed in accordance with a preferred embodiment of the present invention is shown deployed within the aneurysm 40 .
  • the element 310 When in a deployed shape, the element 310 generally includes a central portion 315 and first and second flattened disks 330 / 320 formed at the distal and proximal ends respectively. Only the first flattened disk 330 at the distal end is deployed within the aneurysm 40 whereas the second flattened disk 320 is deployed within the lumen 75 of the blood vessel 60 just outside of the aneurysm 40 , functioning as an anchor to secure the element 310 in its position.
  • the first flattened disk 330 provides a wider coverage than the cup shape 230 shown in FIG. 5.
  • this device 310 may also retain fine vaso-occlusive devices such as vaso-occlusive coils and embolic liquids.
  • the central portion 315 may be conventionally sealed to prevent the fine vaso-occlusive devices from migrating out.
  • a braided tubular element 1 is first constructed. Forming the deployed shape is achieved by using a cylindrical mandrel 95 , as illustrated in FIG. 8. To form the first flattened disk 330 , the distal end is placed on the cylindrical mandrel 95 . The distal tip and a portion of the central tubular portion 315 are then compressed together along the axis of the cylindrical mandrel 95 . This causes the distal end to expand into a flattened disk 330 . To form the second flattened disk 320 , the proximal end is placed on the cylindrical mandrel 95 . The proximal tip and a portion of the central tubular portion 315 are then compressed together along the axis of the cylindrical mandrel 95 . This causes the proximal end to expand into a flattened disk 320 .
  • the assembly of the mandrel 95 and the element 1 is then heated at or above the training temperature to place the element 1 in the austenite phase.
  • the assembly is maintained at that temperature until the deployed shape 310 has been formed.
  • the assembly is cooled to, or below, the martensite finishing temperature to place the element 310 in the martensite phase.
  • the mandrel 95 is removed from the element 310 , and the element 310 is formed into an undeployed shape, e.g., the original tubular shape 1 . This may be achieved by placing the element 310 over the cylindrical mandrel 95 and compressing the flattened disks 320 / 330 to conform to the shape of the cylindrical mandrel 95 , as shown in FIG.
  • the element 1 is configured to expand into its deployed shape upon exposure to a higher temperature, then the element 1 may be placed within a delivery catheter in preparation for deployment, as described above. Alternatively, if the element 110 is configured to expand upon being released by a compressive force, then the element 1 is reheated to, or above, the activation temperature, causing the element 1 to return to the deployed shape 110 and to be configured to maintain the deployed shape 110 irrespective of temperature.
  • the vaso-occlusive devices described above are delivered to an aneurysm within a blood vessel via a delivery catheter.
  • FIGS. 9 ( a )-( c ) a method of deploying a vaso-occlusive device, and in this case the vaso-occlusive device 10 , to the aneurysm 40 via a delivery catheter 450 is illustrated.
  • the catheter 450 is steered to just within the neck 70 of the aneurysm 40 .
  • the vaso-occlusive device 10 is in its undeployed shape, and is coupled to an inner guidewire 465 via an electrolytically severable joint 455 .
  • the assembly of the vaso-occlusive device 10 and the guidewire 465 extends through the lumen of the delivery catheter 450 such that the device 10 is positioned at the distal end of the catheter 450 .
  • the guidewire 465 is then pushed toward the distal end of the catheter 450 causing the vaso-occlusive device 10 to extend out of the distal end of the catheter 450 , through the neck 70 , and into the aneurysm 40 .
  • the portion of the device 10 that is free from the constraints of the catheter 450 expands into its deployed shape, e.g., the distal end 30 flares open.
  • the device 10 may be configured to be in its martensite phase when delivered to the aneurysm 40 and expand upon exposure to the temperature of the aneurysm 40 .
  • the temperature of the device 10 rises and the device 10 enters the austenite phase and expands into its deployed shape.
  • the device 10 may be configured to be super-elastic and automatically expand upon being-unconstrained by the catheter 450 .
  • the guidewire 465 continues to push the device 10 out of the catheter until the proximal end 20 of the device 10 is deployed within the aneurysm 40 , expanding into its deployed shape, e.g., the proximal end 20 flares open, as described above with the distal end 30 .
  • a current is applied to the guidewire 465 , which causes the joint 455 to sever from the proximal end 20 of the catheter 10 .
  • vaso-occlusive device 110 can be delivered within the aneurysm 40 in the manner described immediately above.
  • FIGS. 10 ( a )-( c ) a retractable sheath method of delivering a vaso-occlusive device, and in this case vaso-occlusive device 310 , to the aneurysm 40 is illustrated.
  • the catheter 550 is steered to just within the neck 70 of the aneurysm 40 .
  • the vaso-occlusive device 10 is in its undeployed shape, and is placed over an inner guidewire 565 that extends through the lumen 580 of the delivery catheter 565 .
  • the outer wall 555 of the catheter 565 that defines the lumen 580 functions as a sheath.
  • the assembly of the vaso-occlusive device 310 and the guidewire 565 extends through the lumen 580 of the delivery catheter 450 such that the device 10 is positioned at the distal end of the catheter 550 .
  • the guidewire 565 is then pushed so that the distal end of vaso-occlusive device 310 extends out of the catheter 550 , through the neck 70 , and into the aneurysm 40 .
  • the distal end 330 of the device 310 is allowed to expand into a first flattened disk adjacent the inner wall near the neck 70 within the aneurysm 40 .
  • the device 310 may be configured to be in its martensite phase when delivered to the aneurysm 40 and expand upon exposure to the temperature of the aneurysm 40 .
  • the temperature of the device 310 rises and the device 310 enters the austenite phase and expands into its deployed shape.
  • the device 310 may be configured to be super-elastic and expand upon being unconstrained by the catheter 550 .
  • the guidewire 565 continues to push the device 310 out of the catheter until the proximal end 320 of the device 310 is deployed just outside of the aneurysm 40 , expanding into its deployed shape, e.g., a second flattened disk, as described above with the distal end 330 .
  • the guidewire 565 is pulled out of the device 310 and the catheter 550 is pulled out of the aneurysm 40 and blood vessel 60 .
  • the expanded 310 device is secured in position within the aneurysm 40 and will not be pulled out with the catheter 550 .
  • other types of vaso-occlusive devices such as vaso-occlusive device 310 , can be delivered within the aneurysm 40 in the manner described immediately above.
  • a vaso-occlusive device such as vaso-occlusive device 310
  • finer vaso-occlusive devices 730 may be delivered into the aneurysm 40 to be retained by the device 310 , as illustrated in FIG. 10( d ). This is achieved by maintaining an axial lumen within a vaso-occlusive device to allow a catheter 740 to fit through and insert materials such as vaso-occlusive coils 730 or embolic liquids to further improve thrombogenecity within the aneurysm 700 .
  • FIGS. 11 ( a )-( c ) a push method of delivering a vaso-occlusive device, and in this case vaso-occlusive device 210 , to the aneurysm 40 is illustrated.
  • the catheter 650 is steered to just within the neck 70 of the aneurysm 40 .
  • the vaso-occlusive device 210 is in its undeployed shape, and is placed within the lumen 680 of a delivery catheter 650 near the distal tip of the catheter 650 , which is steered to aneurysm 40 , just outside of the neck 70 .
  • a guidewire 665 extending through the lumen 655 is positioned such that it is capable of pushing the device 210 out of the catheter 650 and into the aneurysm 40 , where the device 230 may expand into its deployed shape, as described above.
  • the guidewire 665 is then pushed so that the distal end of vaso-occlusive device 210 extends out of the catheter 650 , through the neck 70 , and into the aneurysm 40 .
  • the distal end 230 of the device 210 is allowed to expand into a flared open cup shape adjacent the inner wall near the neck 70 within the aneurysm 40 .
  • the device 210 may be configured to be in its martensite phase when delivered to the aneurysm 40 and expand upon exposure to the temperature of the aneurysm 40 .
  • the temperature of the device 210 rises and the device 210 enters the austenite phase and expands into its deployed shape.
  • the device 210 may be configured to be super-elastic and expand upon being unconstrained by the catheter 650 .
  • the guidewire 665 continues to push the device 210 out of the catheter until the proximal end 220 of the device 210 is deployed just outside of the aneurysm 40 , expanding into its deployed shape, e.g., a flattened disk, as described above with the distal end 230 .
  • the catheter 650 is then pulled out of the aneurysm 40 and blood vessel 60 to separate itself from the device 210 .
  • the expanded 210 device is secured in position within the aneurysm 40 and will not be pulled out with the catheter 650 .
  • other types of vaso-occlusive devices such as vaso-occlusive device 210 , can be delivered within the aneurysm 40 in the manner described immediately above.

Abstract

The present invention is directed to systems and methods for occluding an aneurysm having an aneurysmal neck and an aneurysmal inner wall. Generally, a device in accordance with the present invention includes a mesh-like structure that is integrally composed of a shape-memory alloy such as NiTi. The device is deployed within the aneurysm through the aneurysmal neck. The device is configured to be in a deployed state and an undeployed state, and is configured to transition from the undeployed state to the deployed state by exposure to a higher temperature and/or by being unconstrained. The device may function to retain finer vaso-occlusive devices such as vaso-occlusive coils and/or embolic liquids. Furthermore, the device itself may function as a vaso-occlusive device.

Description

    FIELD OF THE INVENTION
  • The present invention relates generally to vaso-occlusion, and more particularly to systems and methods for retaining vaso-occlusive devices within an aneurysm. [0001]
  • BACKGROUND OF THE INVENTION
  • Different implantable medical devices have been developed for treating a number of ailments associated with body lumens. In particular, occlusive devices are useful in filling vascular or other body spaces. Some body spaces, such as vascular aneurysms, are formed due to a weakening in the wall of an artery. Often these aneurysms are the site of internal bleeding and stroke. A variety of different embolic agents are known to be, at least arguably, suitable for treatment of these anomalies. These treatments are commonly known as “artificial vasoocclusion.”[0002]
  • Over the past few years, advancements in the artificial occlusion of vessels and aneurysms have included the delivery and implantation of metal coils as vaso-occlusive devices. Implantable metal coils that are useful as artificial occlusion devices in vasculature lumens or aneurysms are herein referred to as “vaso-occlusive coils.” Vaso-occlusive coils are generally constructed of a wire, usually made of a metal or metal alloy that is wound to a helix. The vaso-occlusive coil assumes an irregular shape upon discharge of the device from the distal end of the catheter. A variety of vaso-occlusive coils are known. For instance, U.S. Pat. No. 4,994,069, issued to Ritchart et al., shows a flexible, preferably coiled, wire for use in small vessel vaso-occlusion. Unlike vaso-occlusive coils used prior to that time, Ritchart et al. teach a coil that is fairly soft and is delivered to the site using a pusher within a catheter lumen. Upon discharge from the delivery catheter, the coil may undertake any number of random or regular configurations used to fill the site. [0003]
  • The coils may be used for small vessel sites, e.g., 0.5-6 mm in diameter. The coils themselves are described as being between 0.010 and 0.030 inches in diameter. The length of the coil wire is typically 15 to 20 times the diameter of the vessel to be occluded. The wire used to make up the coils may be, for instance, 0.002 to 0.006 inches in diameter. Tungsten, platinum, and gold threads or wires are said to be preferred. These coils have a variety of benefits including the fact that they are relatively permanent, they may be easily imaged radiographically, they may be located at a well defined vessel site, and they can be retrieved. [0004]
  • In addition to the various types of space filling mechanisms and geometries of vaso-occlusive coils, other particularized features of coil designs, such as mechanisms for delivering vaso-occlusive coils through delivery catheters and implanting them in a desired occlusion site, have also been described. The examples of categories of vaso-occlusive coils based upon their delivery mechanisms include pushable coils, mechanically detachable coils, and electrolytically detachable coils. [0005]
  • One example of the type of vaso-occlusive coil referred to above as the “pushable coil” is disclosed in Ritchart et al., discussed above. Pushable coils are commonly provided in a cartridge and are pushed or “plunged” from the cartridge into a delivery catheter lumen. A pusher advances the pushable coil through and out of the delivery catheter lumen and into the site for occlusion. [0006]
  • Mechanically detachable vaso-occlusive coils are typically integrated with a pusher rod and are mechanically detached from the distal end of that pusher after exiting a delivery catheter. Examples of such mechanically detachable vaso-occlusive coils are found in U.S. Pat. No. 5,261,916 to Engelson or U.S. Pat. No. 5,250,071 to Palermo. [0007]
  • Finally, examples of electrolytically detachable vaso-occlusive coils may be found in U.S. Pat. Nos. 5,122,136 and 5,354,295, each issued to Guglielmi et al. In these devices, the vaso-occlusive portion of the assembly is attached to a pusher via a small, electrolytically severable joint. The electrolytically severable joint is severed by the placement of an appropriate voltage on the core wire. The joint erodes in preference either to the vaso-occlusive coil itself or to the pusher core wire. [0008]
  • As noted above, aneurysms present a particularly acute medical risk due to the dangers of potential rupture of the thin wall inherent in such aneurysms. Occlusion of aneurysms by use of vaso-occlusive coils without occluding the adjacent artery is a special challenge and is a desirable method of reducing such risk of rupture. These vaso-occlusive devices are typically placed in an aneurysm in a manner described in U.S. Pat. No. 4,739,768 issued to Engelson. In particular, a microcatheter is initially steered into or adjacent to the entrance of an aneurysm, typically aided by the use of a steerable guidewire. The wire is then withdrawn from the microcatheter lumen and replaced by the vaso-occlusive coil. The vaso-occlusive coil is advanced through and out of the microcatheter, desirably being completely delivered into the aneurysm. [0009]
  • However, after, or perhaps during, delivery of the coil into the aneurysm, there is a specific risk that a portion of the coil might migrate out of the aneurysm entrance zone and into the feeding vessel. The presence of the coil in that feeding vessel may cause a highly undesirable occlusion there. Also, there is a quantifiable risk that the blood flow in the vessel and aneurysm may induce movement of the coil farther out of the aneurysm, resulting in a more developed embolus in the feeding vessel. [0010]
  • One type of aneurysm, commonly known as a “wide neck aneurysm,” is known to present particular difficulty in the placement and retention of vaso-occlusive coils, because vaso-occlusive coils lacking substantial secondary shape strength may be difficult to maintain in position within an aneurysm no matter how skillfully they are placed. Wide neck aneurysms are herein referred to as aneurysms of vessel walls having a neck or “entrance zone” from the adjacent vessel, wherein the entrance zone has a diameter that either: (1) is at least 80% of the largest diameter of the aneurysm; or (2) is clinically observed to be too wide effectively to retain vaso-occlusive coils that are deployed using the techniques discussed above. [0011]
  • One approach to occlude such an aneurysm is described in U.S. Pat. No. 6,168,622, which describes a vaso-occlusive device with a secondary shape having a bulbous body portion and an anchor. The bulbous body portion is deployed within the aneurysm while the anchor is set just outside of the aneurysm, covering the aneurysm's neck or entrance zone. The device is integrally formed from a tube—clamped at both ends—of braided Nickel-Titanium (NiTi) wires. The bulbous body functions to occlude the aneurysm, while the anchor covers the entrance zone. In some cases, it may still be desirable to deploy vaso-occlusive coils with such a device, but the bulbous body of the vaso-occlusive device does not provide much space within the aneurysm to allow for insertion and deployment of the coils. [0012]
  • Accordingly, an improved system and method for occluding an aneurysm neck would be desirable. [0013]
  • SUMMARY OF INVENTION
  • The present invention is directed to systems and methods for occluding an aneurysm having an aneurysmal neck and an aneurysmal inner wall. Generally, a device in accordance with the present invention includes a mesh-like structure that may be integrally composed of a shape-memory alloy such as NiTi. The device may be deployed within the aneurysm through the aneurysmal neck. The device may be configured to be in a deployed state and an undeployed state, and may be configured to transition from the undeployed state to the deployed state by exposure to a higher temperature and/or by being released from a compressive force. The device may function to retain finer vaso-occlusive devices such as vaso-occlusive coils and/or embolic liquids. Furthermore, the device itself may function as a vaso-occlusive device. The device may be delivered to the aneurysm by, e.g., a catheter. [0014]
  • In accordance with a first aspect of the present invention, at least one of the proximal and distal ends of the mesh-like structure is configured to be inserted through the aneurysmal neck when in an undeployed state, and configured to flare open and expand against at least a portion of the aneurysmal inner wall when in a deployed state. Having a flared open end may advantageously allow the device to conform to the shape of the aneurysm. [0015]
  • In accordance with another aspect of the present invention, the distal end of the mesh-like structure may be configured to be inserted through the aneurysmal neck when in an undeployed state and configured to expand into a retainer against at least a portion of the aneurysmal inner wall when in a deployed state. The proximal end may be configured to expand into an anchor just outside of the aneurysm to secure the mesh-like structure in position. [0016]
  • Other objects and features of the present invention will become apparent from consideration of the following description taken in conjunction with the accompanying drawings. [0017]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • In order to better appreciate how the above-recited and other advantages and objects of the present inventions are obtained, a more particular description of the present inventions briefly described above will be rendered by reference to specific embodiments thereof, which are illustrated in the accompanying drawings. Understanding that these drawings depict only typical embodiments of the invention and are not therefore to be considered limiting of its scope, the invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which: [0018]
  • FIG. 1 is an illustration of a vaso-occlusive device constructed in accordance with a preferred embodiment of the present inventions, wherein the vaso-occlusive device is shown fully deployed within an aneurysm; [0019]
  • FIGS. [0020] 2(a) and 2(b) illustrate one preferred method of manufacturing the vaso-occlusive device of FIG. 1 in accordance with the present inventions;
  • FIG. 3 is an illustration of another vaso-occlusive device constructed in accordance with a preferred embodiment of the present inventions, wherein the vaso-occlusive device is shown fully deployed within an aneurysm; [0021]
  • FIG. 4 illustrates one preferred method of manufacturing the vaso-occlusive device of FIG. 3 in accordance with the present inventions; [0022]
  • FIG. 5 is an illustration of still another vaso-occlusive device constructed in accordance with a preferred embodiment of the present inventions, wherein the vaso-occlusive device is shown fully deployed within an aneurysm; [0023]
  • FIG. 6 illustrates one preferred method of manufacturing the vaso-occlusive device of FIG. 5 in accordance with the present inventions; [0024]
  • FIG. 7 is an illustration of still another vaso-occlusive device constructed in accordance with a preferred embodiment of the present inventions, wherein the vaso-occlusive device is shown fully deployed within an aneurysm; [0025]
  • FIG. 8 illustrates one preferred method of manufacturing the vaso-occlusive device of FIG. 7 in accordance with the present inventions; [0026]
  • FIGS. [0027] 9(a)-(c) illustrate a preferred method of delivering and deploying the vaso-occlusive device of FIG. 1 into the aneurysm;
  • FIGS. [0028] 10(a)-(d) illustrate a preferred method of delivering and deploying the vaso-occlusive device of FIG. 7 into the aneurysm; and
  • FIGS. [0029] 11(a)-(c) illustrate a preferred method of delivering and deploying the vaso-occlusive device of FIG. 5 into the aneurysm.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
  • Turning to FIG. 1, a vaso-[0030] occlusive element 10 constructed in accordance with a preferred embodiment of the present invention is shown completely deployed within an aneurysm 40 of a blood vessel 60. The aneurysm 40 is shown with an oppositely disposed neck 70 and dome 45. When deployed in its secondary shape, i.e., its deployed shape, the vaso-occlusive element 10 generally includes a central tubular element 15 and proximal 20 and distal 30 ends that are flared open into “umbrella” shapes. As illustrated, the flared opened ends 20/30 advantageously conform to the shape of the aneurysm 40. The diameter of the proximal end 20 of the vaso-occlusive element 10 is larger than the neck 70, and thus the proximal end 20 may completely cover the neck 70.
  • As will be described in further detail below, the vaso-[0031] occlusive element 10 is manufactured from a relatively dense braid. In this manner, the proximal end 20 may densely cover the neck 70 and function as a retainer. Thus, finer vaso-occlusive devices, such as vaso-occlusive coils or embolic liquids, may effectively be retained within the aneurysm 40, or at the least, the likelihood of these devices migrating out from the aneurysm 40 is minimized. Further, as can be appreciated by one of ordinary skill in the art, the relatively dense coverage of the proximal end 20 allows the vaso-occlusive element 10 itself to function as a vaso-occlusive device. The flared open distal end 30 is placed adjacent the dome 45 of the aneurysm 40 and allows the element 10 to safely conform to the shape of the dome 45. This allows for the distal end 30 to function as an anchor and secure itself within the aneurysm 40 without the need to conform to the entire shape of the aneurysm 40. Thus, the element 10 may conform to a large variety of shapes and sizes of aneurysms 40 since the element 10 need only be secured within the aneurysm 40 by conforming the flared open distal end 30 to the dome 45.
  • Turning to FIGS. [0032] 2(a)-(b), one preferred method of manufacturing the vaso-occlusive device 10 will now be described. First, a braided tubular element 1 is constructed by braiding multiple fine wires 2 together. The tubular element 1 may also be formed of wires with varying diameters braided together. It may be desirable to use a larger number of wires 2 when forming the tubular element 1, resulting in a relatively dense braid, which provides denser coverage within the aneurysm 40. Optionally, the tubular element 1 may be radiopaque. One method involves braiding a radiopaque fiber, such as platinum, Pt, or gold, Au, into the tubular element 1. Another method involves plating or coating the tubular element 1 with radiopaque material. Additionally, one or more radiopaque markers may be added to the tubular element 1.
  • Preferably, the [0033] wires 2 are made from a shape memory alloy, which can be of any type, but preferably is a “one way” trainable shape memory alloy. A preferable shape memory alloy for forming the braided tubular element 1 is Nickel-Titanium (NiTi)—e.g., 144 strands of 0.001″ NiTi wires. Shape memory alloys comprise a unique class of metal alloys that, once trained, are configured to “remember” a preselected shape, i.e., deployed shape, and can return to the preselected shape even if subsequently reshaped. To be trained to “remember” a first preselected shape, the shape memory alloy is molded and heated at or above a training, or austenite, temperature to place the shape memory alloy in an austenite phase. In the austenite phase, the shape memory alloy is formed in the first preselected shape and then, once formed, is permitted to cool to a martensite finish temperature, whereupon the shape memory alloy enters a martensite phase. The martensite finish temperature can be any temperature that is less than the training temperature. Upon entering the martensite phase, the shape memory alloy has been trained to “remember” the first preselected shape. While in the martensite phase, the alloy is in a soft state and is formed into a second preselected shape, e.g., an undeployed shape. The shape memory alloy in the martensite phase is configured to maintain the second preselected shape and, if subsequently reheated to an activation temperature, automatically returns to the first preselected shape. The activation temperature can comprise any temperature that is greater than the martensite finish temperature and generally approximately equals the training temperature. Once the first preselected shape has been recovered, the shape memory alloy is configured to maintain the first preselected shape irrespective of temperature. Generally, as can be appreciated by one of ordinary skill in the art, the training, martensite finishing, and activation temperatures for a shape memory alloy are adjustable, depending on the composition. For example, a slight extra amount of Nickel added to a NiTi alloy composition can change the training temperature from 0° C. to 100° C.
  • Generally, the vaso-[0034] occlusive device 10 described above is delivered to the aneurysm 40 via a delivery catheter. The catheter delivers the device 10 to the aneurysm 40 and during the delivery, the device 10 maintains an undeployed shape, e.g., the original tubular shape—methods of delivery will be described in more detail below. When the device 10 is deployed, the device 10 expands into its deployed shape, e.g., having flared open proximal and distal ends 20/30, as shown in FIG. 1. Using a shape memory alloy to form the device 10 provides for alternative methods of expanding the device 10 into its deployed shape within the aneurysm 40.
  • One method involves configuring the [0035] device 10 to self-expand within the aneurysm 40 when deployed and exposed to the temperature of the aneurysm 40. To configure the device 10 to self-expand within the aneurysm 40 when deployed and exposed to the temperature of the aneurysm 40, the training and activation temperatures are adjusted to be at, or just below, the temperature of the aneurysm, which is approximately 37° Celsius—the human body temperature. The martensite temperature is adjusted to be at a lower temperature. With these temperatures set, the device 10 is heated to, or above the training temperature—austenite phase—and shaped into its desired deployed shape, as described above. Then, the temperature is lowered to, or below, the martensite finish temperature—martensite phase—and shaped into its desired undeployed shape. Subsequently, the device 10 is then placed inside the catheter as will be described below. The catheter can be constructed of a material that insulates the device 10 from the outside environment and maintains the temperature of the device 10 below the activation temperature. Thus, when the catheter is inserted into the lumen 75 of the blood vessel 60, the device 10 does not expand into its deployed shape within the catheter. When the device 10 is deployed into the aneurysm 40 and exposed to the aneurysm temperature, the temperature of the device will rise at or above the activation temperature, and the device 10 will expand into its deployed shape. Because the alloy is preferably “one way” trained, the device 10 will then be configured to maintain the deployed shape irrespective of the temperature, as described above.
  • An alternative method for expanding the [0036] device 10 into its deployed shape within the aneurysm utilizes the super-elastic characteristic of shape memory alloys. After the device 10 is configured to maintain its deployed shape irrespective of the temperature, as described above, the device 10 is then maintained in its austenite phase. When the device 10 is in its austenite phase, the device 10 is super-elastic, i.e., the device 10 may be deformed to a certain degree and still be able to return to its deployed shape. The device 10 is then placed within the catheter as will be described below, with the inner wall of the catheter compressing the device 10 into its undeployed shape. When the device 10 is released out of the catheter into the aneurysm 40, the uncompressed device 10 automatically expands into its deployed shape because of its super-elasticity.
  • Further details on the structure and manufacturing process of braided tubular elements [0037] 1 are disclosed in U.S. Pat. No. 6,168,622 issued to Mazzochhi, column 4, line 33 to column 6, line 24, and FIGS. 1A and 1B, of which are hereby incorporated by reference.
  • Forming the deployed shape shown in FIG. 1 is achieved by using two [0038] mandrels 85, each having a cylindrical portion 90 and an umbrella dome-shaped mold 85, as illustrated in FIG. 2(a). To flare open the ends of the element 1, each end is placed over the cylindrical portion 90 of a mandrel 85 and compressed against the dome 85, causing the ends to conform to the shape of the dome 85 and flare open. The assembly of the two mandrels 80 and the element 1 is then heated at or above the training temperature to place the element 1 in the austenite phase. The assembly is maintained at that temperature until the deployed shape has been formed.
  • Then, the assembly is cooled to, or below, the martensite finishing temperature to place the element [0039] 1 in the martensite phase. In the martensite phase, the mandrels 80 are removed from the element 1, and the element 1 is formed into an undeployed shape, e.g., the original tubular shape. This may be achieved by placing the element 1 over a cylindrical mandrel 95 and compressing the flared ends to conform to the shape of the cylindrical mandrel 95, as shown in FIG. 2b. Subsequently, the element 1 may be reheated to the activation temperature, causing the element 1 to return to the deployed shape. Once the deployed shape has been recovered, the element 1 is configured to maintain the deployed shape irrespective of temperature.
  • Turning to FIG. 3, another vaso-[0040] occlusive element 110 constructed in accordance with a preferred embodiment of the present invention is shown completely deployed within the aneurysm 40. As with the embodiment in FIG. 1, the vaso-occlusive element 110, when deployed, generally includes a central tubular element 115 and a flared distal end 130. The vaso-occlusive element 110 further includes a proximal end 120 shaped as a flattened disk, which functions as a retainer. The proximal end 130 has a diameter larger than the diameter of the neck 70, and thus completely covers the entrance zone 150. The flattened disk 130 has a layer of braided wires on both sides, and thus may advantageously provide two layers of braided wires to cover the entrance zone 150 instead of one layer with the flared open proximal end 20 shown in FIG. 1. As with the flared open distal end 30 of the vaso-occlusive element 10, shown in FIG. 1, the flared open distal end 130 is placed adjacent the dome 45 of the aneurysm 40 and allows the element 110 to safely conform to the shape of the dome 45.
  • Turning to FIG. 4, one preferred method of manufacturing the vaso-[0041] occlusive device 110 shown in FIG. 3 will now be described. As described above, a braided tubular element 1 is first constructed. Forming the deployed shape is achieved by using one of the mandrels 85 shown in FIG. 2(a) and the cylindrical mandrel shown in FIG. 2(b), as illustrated in FIG. 4. As described above, to flare open the distal end of the element 1, the distal end is placed over the cylindrical portion 90 of the mandrel 85 with the dome 80 and compressed against the dome 80, causing the distal end to flare open. To form the flattened disk 120, the proximal end is placed on the cylindrical mandrel 95. The proximal tip and a portion of the central tubular portion 115 are then compressed together along the axis of the cylindrical mandrel 95. This causes the proximal end to expand into a flattened disk 120.
  • The assembly of the two [0042] mandrels 80/95 and the element 1 is then heated at or above the training temperature to place the element 1 in the austenite phase. The assembly is maintained at that temperature until the deployed shape 110 has been formed. Then, the assembly is cooled to, or below, the martensite finishing temperature to place the element 110 in the martensite phase. In the martensite phase, the mandrels 80/95 are removed from the element 110, and the element 110 is formed into an undeployed shape, e.g., the original tubular shape 1. This is achieved by placing the element 110 over the cylindrical mandrel 95 and compressing the flared open end and flattened disk to conform to the shape of the cylindrical mandrel 95, as shown in FIG. 2(b). If the element 1 is configured to expand into its deployed shape upon exposure to a higher temperature, then the element 1 may be placed within a delivery catheter in preparation for deployment, as described above. Alternatively, if the element 110 is configured to expand upon being released by a compressive force, then the element 1 is reheated to, or above, the activation temperature, causing the element 1 to return to the deployed shape 110 and to be configured to maintain the deployed shape 110 irrespective of temperature.
  • Turning to FIG. 5, another vaso-[0043] occlusive element 210 constructed in accordance with a preferred embodiment of the present invention is shown deployed within the aneurysm 40. When in a deployed shape, the element 210 generally includes a central portion 215 and a distal end flared open into a “cup” shape 230. Alternatively, the distal end may be flared open into a “cone” shape. The vaso-occlusive element 210 further includes a proximal end 220 shaped as a flattened disk. The proximal end 220 has a diameter larger than the diameter of the neck 70. Only the flared open cup shape 230 is deployed within the aneurysm 40, whereas the flattened disk 220 is deployed in the lumen 75 of the blood vessel 60 just outside of the aneurysm 40, functioning as an anchor for the element 210. The cup shaped distal end 230 may retain fine vaso-occlusive devices such as vaso-occlusive coils and embolic liquids.
  • Turning to FIG. 6, one preferred method of manufacturing the vaso-[0044] occlusive device 310 shown in FIG. 5 will now be described. As described above, a braided tubular element 1 is first constructed. Forming the deployed shape is achieved by using a mandrel 280 having a cup shaped dome 285 facing outward coupled to a cylindrical portion 290 and a cylindrical mandrel 95. To form the cup shape, the distal end of the element 1 is placed over the cylindrical portion 290 of the mandrel 280 having the dome 285 and compressed against the dome 285, causing the distal end to flare open into a cup shape. To form the flattened disk, the proximal end is placed over the cylindrical mandrel 95. The proximal tip and a portion of the central tubular portion 215 are then compressed together along the axis of the cylindrical mandrel 95. This causes the proximal end to expand into a flattened disk 220.
  • The assembly of the two [0045] mandrels 280/95 and the element 1 is then heated at or above the training temperature to place the element 1 in the austenite phase. The assembly is maintained at that temperature until the deployed shape 210 has been formed. Then, the assembly is cooled to, or below, the martensite finishing temperature to place the element 210 in the martensite phase. In the martensite phase, the mandrels 280/95 are removed from the element 210, and the element 210 is formed into an undeployed shape, e.g., the original tubular shape 1. This may be achieved by placing the element 210 over the cylindrical mandrel 95 and compressing the flared open end and flattened disk to conform to the shape of the cylindrical mandrel 95. If the element 1 is configured to expand into its deployed shape upon exposure to a higher temperature, then the element 1 may be placed within a delivery catheter in preparation for deployment, as described above. Alternatively, if the element 110 is configured to expand upon being released by a compressive force, then the element 1 is reheated to, or above, the activation temperature, causing the element 1 to return to the deployed shape 110 and to be configured to maintain the deployed shape 110 irrespective of temperature.
  • Turning to FIG. 7, another vaso-[0046] occlusive element 310 constructed in accordance with a preferred embodiment of the present invention is shown deployed within the aneurysm 40. When in a deployed shape, the element 310 generally includes a central portion 315 and first and second flattened disks 330/320 formed at the distal and proximal ends respectively. Only the first flattened disk 330 at the distal end is deployed within the aneurysm 40 whereas the second flattened disk 320 is deployed within the lumen 75 of the blood vessel 60 just outside of the aneurysm 40, functioning as an anchor to secure the element 310 in its position. The first flattened disk 330 provides a wider coverage than the cup shape 230 shown in FIG. 5. As with the other devices described above, this device 310 may also retain fine vaso-occlusive devices such as vaso-occlusive coils and embolic liquids. The central portion 315 may be conventionally sealed to prevent the fine vaso-occlusive devices from migrating out.
  • Turning to FIG. 8, one preferred method of manufacturing the vaso-[0047] occlusive device 310 shown in FIG. 7 will now be described. As described above, a braided tubular element 1 is first constructed. Forming the deployed shape is achieved by using a cylindrical mandrel 95, as illustrated in FIG. 8. To form the first flattened disk 330, the distal end is placed on the cylindrical mandrel 95. The distal tip and a portion of the central tubular portion 315 are then compressed together along the axis of the cylindrical mandrel 95. This causes the distal end to expand into a flattened disk 330. To form the second flattened disk 320, the proximal end is placed on the cylindrical mandrel 95. The proximal tip and a portion of the central tubular portion 315 are then compressed together along the axis of the cylindrical mandrel 95. This causes the proximal end to expand into a flattened disk 320.
  • The assembly of the [0048] mandrel 95 and the element 1 is then heated at or above the training temperature to place the element 1 in the austenite phase. The assembly is maintained at that temperature until the deployed shape 310 has been formed. Then, the assembly is cooled to, or below, the martensite finishing temperature to place the element 310 in the martensite phase. In the martensite phase, the mandrel 95 is removed from the element 310, and the element 310 is formed into an undeployed shape, e.g., the original tubular shape 1. This may be achieved by placing the element 310 over the cylindrical mandrel 95 and compressing the flattened disks 320/330 to conform to the shape of the cylindrical mandrel 95, as shown in FIG. 2(b). If the element 1 is configured to expand into its deployed shape upon exposure to a higher temperature, then the element 1 may be placed within a delivery catheter in preparation for deployment, as described above. Alternatively, if the element 110 is configured to expand upon being released by a compressive force, then the element 1 is reheated to, or above, the activation temperature, causing the element 1 to return to the deployed shape 110 and to be configured to maintain the deployed shape 110 irrespective of temperature.
  • Generally, as mentioned above, the vaso-occlusive devices described above are delivered to an aneurysm within a blood vessel via a delivery catheter. Referring to FIGS. [0049] 9(a)-(c), a method of deploying a vaso-occlusive device, and in this case the vaso-occlusive device 10, to the aneurysm 40 via a delivery catheter 450 is illustrated. Turning first to FIG. 9(a), the catheter 450 is steered to just within the neck 70 of the aneurysm 40. At this point, the vaso-occlusive device 10 is in its undeployed shape, and is coupled to an inner guidewire 465 via an electrolytically severable joint 455. The assembly of the vaso-occlusive device 10 and the guidewire 465 extends through the lumen of the delivery catheter 450 such that the device 10 is positioned at the distal end of the catheter 450.
  • Turning to FIG. 9([0050] b), the guidewire 465 is then pushed toward the distal end of the catheter 450 causing the vaso-occlusive device 10 to extend out of the distal end of the catheter 450, through the neck 70, and into the aneurysm 40. As the vaso-occlusive device 10 is pushed out of the catheter 450, the portion of the device 10 that is free from the constraints of the catheter 450 expands into its deployed shape, e.g., the distal end 30 flares open.
  • As described above, the [0051] device 10 may be configured to be in its martensite phase when delivered to the aneurysm 40 and expand upon exposure to the temperature of the aneurysm 40. Thus, when outside of the catheter 450, the temperature of the device 10 rises and the device 10 enters the austenite phase and expands into its deployed shape. Alternatively, the device 10 may be configured to be super-elastic and automatically expand upon being-unconstrained by the catheter 450.
  • Turning now to FIG. 9([0052] c), the guidewire 465 continues to push the device 10 out of the catheter until the proximal end 20 of the device 10 is deployed within the aneurysm 40, expanding into its deployed shape, e.g., the proximal end 20 flares open, as described above with the distal end 30. To release the device 10 from the catheter 450 a current is applied to the guidewire 465, which causes the joint 455 to sever from the proximal end 20 of the catheter 10. Further discussion of the construction of, placement of, and other physical details of such electrolytically severable joints may be found in U.S. Pat. No. 5,122,136 to Guglielmi et al.; U.S. Pat. No. 5,354,295 to Guglielmi et al.; and U.S. Pat. No. 5,624,449 to Pham et al; and others. It should be noted that other types of vaso-occlusive devices, such as vaso-occlusive device 110, can be delivered within the aneurysm 40 in the manner described immediately above.
  • Alternatively, referring to FIGS. [0053] 10(a)-(c), a retractable sheath method of delivering a vaso-occlusive device, and in this case vaso-occlusive device 310, to the aneurysm 40 is illustrated. Turning to FIG. 10(a), the catheter 550 is steered to just within the neck 70 of the aneurysm 40. At this point, the vaso-occlusive device 10 is in its undeployed shape, and is placed over an inner guidewire 565 that extends through the lumen 580 of the delivery catheter 565. The outer wall 555 of the catheter 565 that defines the lumen 580 functions as a sheath. The assembly of the vaso-occlusive device 310 and the guidewire 565 extends through the lumen 580 of the delivery catheter 450 such that the device 10 is positioned at the distal end of the catheter 550.
  • Turning to FIG. 10([0054] b), the guidewire 565 is then pushed so that the distal end of vaso-occlusive device 310 extends out of the catheter 550, through the neck 70, and into the aneurysm 40. Once unconstrained from the catheter 550, the distal end 330 of the device 310 is allowed to expand into a first flattened disk adjacent the inner wall near the neck 70 within the aneurysm 40.
  • As described above, the [0055] device 310 may be configured to be in its martensite phase when delivered to the aneurysm 40 and expand upon exposure to the temperature of the aneurysm 40. Thus, when outside of the catheter 550, the temperature of the device 310 rises and the device 310 enters the austenite phase and expands into its deployed shape. Alternatively, the device 310 may be configured to be super-elastic and expand upon being unconstrained by the catheter 550.
  • Turning now to FIG. 10([0056] c), the guidewire 565 continues to push the device 310 out of the catheter until the proximal end 320 of the device 310 is deployed just outside of the aneurysm 40, expanding into its deployed shape, e.g., a second flattened disk, as described above with the distal end 330. To release the device 310 from the catheter 450, the guidewire 565 is pulled out of the device 310 and the catheter 550 is pulled out of the aneurysm 40 and blood vessel 60. The expanded 310 device is secured in position within the aneurysm 40 and will not be pulled out with the catheter 550. It should be noted that other types of vaso-occlusive devices, such as vaso-occlusive device 310, can be delivered within the aneurysm 40 in the manner described immediately above.
  • As mentioned above, a vaso-occlusive device, such as vaso-[0057] occlusive device 310, may function as a vaso-occlusive device and/or function as a vaso-occlusive device retainer. In this regard, after deployment, finer vaso-occlusive devices 730 may be delivered into the aneurysm 40 to be retained by the device 310, as illustrated in FIG. 10(d). This is achieved by maintaining an axial lumen within a vaso-occlusive device to allow a catheter 740 to fit through and insert materials such as vaso-occlusive coils 730 or embolic liquids to further improve thrombogenecity within the aneurysm 700.
  • In another alternative, turning to FIGS. [0058] 11(a)-(c), a push method of delivering a vaso-occlusive device, and in this case vaso-occlusive device 210, to the aneurysm 40 is illustrated. Turning to FIG. 11(a), the catheter 650 is steered to just within the neck 70 of the aneurysm 40. At this point, the vaso-occlusive device 210 is in its undeployed shape, and is placed within the lumen 680 of a delivery catheter 650 near the distal tip of the catheter 650, which is steered to aneurysm 40, just outside of the neck 70. A guidewire 665, extending through the lumen 655 is positioned such that it is capable of pushing the device 210 out of the catheter 650 and into the aneurysm 40, where the device 230 may expand into its deployed shape, as described above.
  • Turning to FIG. 11([0059] b), the guidewire 665 is then pushed so that the distal end of vaso-occlusive device 210 extends out of the catheter 650, through the neck 70, and into the aneurysm 40. Once unconstrained from the catheter 550, the distal end 230 of the device 210 is allowed to expand into a flared open cup shape adjacent the inner wall near the neck 70 within the aneurysm 40.
  • As described above, the [0060] device 210 may be configured to be in its martensite phase when delivered to the aneurysm 40 and expand upon exposure to the temperature of the aneurysm 40. Thus, when outside of the catheter 650, the temperature of the device 210 rises and the device 210 enters the austenite phase and expands into its deployed shape. Alternatively, the device 210 may be configured to be super-elastic and expand upon being unconstrained by the catheter 650.
  • Turning now to FIG. 11([0061] c), the guidewire 665 continues to push the device 210 out of the catheter until the proximal end 220 of the device 210 is deployed just outside of the aneurysm 40, expanding into its deployed shape, e.g., a flattened disk, as described above with the distal end 230. The catheter 650 is then pulled out of the aneurysm 40 and blood vessel 60 to separate itself from the device 210. The expanded 210 device is secured in position within the aneurysm 40 and will not be pulled out with the catheter 650. It should be noted that other types of vaso-occlusive devices, such as vaso-occlusive device 210, can be delivered within the aneurysm 40 in the manner described immediately above.
  • While embodiments of the present invention have been shown and described, various modifications may be made without departing from the spirit and scope of the present invention, and all such modifications and equivalents are intended to be covered. [0062]

Claims (72)

What is claimed is:
1. A vaso-occlusive device for use in occluding an aneurysm having an aneurysmal neck and an aneurysmal inner wall, comprising:
a mesh-like structure comprising a proximal end and a distal end, at least one of the proximal and distal ends configured to be inserted through the aneurysmal neck when in an undeployed state, and configured to flare open and expand against at least a portion of the aneurysmal inner wall when in a deployed state.
2. The vaso-occlusive device of claim 1, wherein the mesh-like structure further comprises a central tubular element.
3. The vaso-occlusive device of claim 1, wherein the at least one proximal end and distal end comprises the distal end.
4. The vaso-occlusive device of claim 1, wherein the at least proximal end and distal end comprises the proximal end.
5. The vaso-occlusive device of claim 3, wherein the proximal end of the mesh-like structure is configured to be inserted through the aneurysmal neck when in the undeployed state, and configured to expand into a flattened disk against at least a portion of the aneurysmal inner wall when in the deployed state.
6. The vaso-occlusive device of claim 1, wherein the at least one of the proximal end and distal end is configured to expand by heat activation into the deployed state.
7. The vaso-occlusive device of claim 1, wherein the at least one of the proximal end and distal end is configured to expand into the deployed state upon release of a compressive force.
8. The vaso-occlusive device of claim 1, wherein the mesh-like structure is formed from a plurality of braided fine wires.
9. The vaso-occlusive device of claim 1, wherein the mesh-like structure is composed of a NiTi alloy.
10. The vaso-occlusive device of claim 9, wherein the fine wires have varying diameters.
11. The vaso-occlusive device of claim 9, wherein one or more of the fine wires are radiopaque.
12. The vaso-occlusive device of claim 1, wherein the mesh-like structure is coated with radiopaque material.
13. The vaso-occlusive device of claim 1, further comprising radiopaque markers coupled to the mesh-like structure.
14. A catheter assembly for occluding an aneurysm having an aneurysmal neck and an aneurysmal inner wall, comprising:
a delivery catheter having a distal end; and
a mesh-like structure detachably coupled to the distal end of the catheter, the mesh-like structure comprising a proximal end and a distal end, at least one of the proximal and distal ends configured to be inserted through the aneurysmal neck when in an undeployed state, and configured to flare open and expand against at least a portion of the aneurysmal inner wall when in a deployed state.
15. The catheter assembly of claim 14, wherein the mesh-like structure further comprises a central tubular element.
16. The catheter assembly of claim 14, wherein the at least one proximal end and distal end comprises the distal end.
17. The catheter assembly of claim 1, wherein the at least proximal end and distal end comprises the proximal end.
18. The catheter assembly of claim 16, wherein the proximal end of the mesh-like structure is configured to be inserted through the aneurysmal neck when in the undeployed state, and configured to expand into a flattened disk against at least a portion of the aneurysmal inner wall when in the deployed state.
19. The catheter assembly of claim 14, wherein the at least one of the proximal end and distal end is configured to expand by heat activation into the deployed state.
20. The catheter assembly of claim 14, wherein the at least one of the proximal end and distal end is configured to expand into the deployed state upon releasing a compressive force.
21. The catheter assembly of claim 14, wherein the mesh-like structure is formed from a plurality of braided fine wires.
22. The catheter assembly of claim 14, wherein the mesh-like structure is composed of a NiTi alloy.
23. The catheter assembly of claim 21, wherein the fine wires have varying diameters.
24. The catheter assembly of claim 21, wherein the fine wires are radiopaque.
25. The catheter assembly of claim 14, wherein the mesh-like structure is coated with radiopaque material.
26. The catheter assembly of claim 14, further comprising radiopaque markers coupled to the mesh-like structure.
27. The catheter assembly in claim 14, wherein the mesh-like structure is capable of being delivered to the aneurysm using a method selected from a group consisting of an electrolytically severable method, a retractable sheath method, and a push method.
28. A method of occluding an aneurysm with a mesh-like structure, the aneurysm having an aneurysmal neck and an aneurysmal inner wall, comprising:
delivering the mesh-like structure to the aneurysm;
inserting an end of the mesh-like structure through the aneurysmal neck; and
flaring the end of the mesh-like structure open to expand against at least a portion of the aneurysmal inner wall.
29. The method of claim 28, wherein the end of the mesh-like structure comprises a distal end of the mesh-like structure.
30. The method of claim 28, wherein the end of the mesh-like structure comprises a proximal end of the mesh-like structure.
31. The method of claim 28, wherein the aneurysm comprises a dome, and the end of the mesh-like structure is expanded against the aneurysmal inner wall adjacent the dome.
32. The method of claim 28, further comprising:
inserting another end of the mesh-like structure through the aneurysmal neck; and
expanding the other end of the mesh-like structure into a flatten disk against at least a portion of the aneurysmal inner wall.
33. The method of claim 32, wherein the aneurysm comprises a dome, the end of the mesh-like structure is expanded against the aneurysmal inner wall adjacent the dome, and the other end of the mesh-like structure is expanded against the aneurysmal inner wall adjacent the aneurysmal neck.
34. The method of claim 28, wherein the mesh-like structure is heat activated to flare the end open.
35. The method of claim 28, wherein a compressive force is released from the mesh-like structure to flare the end open.
36. The method of claim 35, wherein the mesh-like structure is delivered to the aneurysm with a catheter.
37. The method of claim 36, further comprising releasing the mesh-like structure from the catheter using a method selected from a group consisting of an electrolytically severable method, a retractable sheath method, and a push method.
38. A vaso-occlusive device for use in occluding an aneurysm having an aneurysmal neck and an aneurysmal inner wall, the aneurysm residing in a vessel having a vessel inner wall, the device comprising:
a mesh-like structure comprising a retainer and an anchor, the retainer configured to be inserted through the aneurysmal neck when in an undeployed state, and configured to expand against a portion of the aneurysmal inner wall surrounding the aneurysmal neck when in a deployed state, wherein a portion of the aneurysmal inner wall is not covered by the mesh-like structure, the anchor configured to expand against a portion of the vessel inner wall adjacent the aneurysmal neck when in a deployed state.
39. The vaso-occlusive device of claim 38, wherein the mesh-like structure further comprises a central tubular element, and the retainer and anchor are formed at opposing ends of the central tubular element.
40. The vaso-occlusive device in claim 38, wherein the retainer and anchor are shaped as flattened disks.
41. The vaso-occlusive device in claim 38, wherein the retainer is shaped as a flared open cup and the anchor is shaped as a flattened disk.
42. The vaso-occlusive device of claim 38, wherein the retainer and anchor are configured to expand by heat activation into the deployed state.
43. The vaso-occlusive device of claim 38, wherein the retainer and anchor are s configured to expand into the deployed state when unconstrained.
44. The vaso-occlusive device of claim 38, wherein the mesh-like structure is formed from a plurality of braided fine wires.
45. The vaso-occlusive device of claim 38, wherein the mesh-like structure is composed of a NiTi alloy.
46. The vaso-occlusive device of claim 44, wherein the plurality of fine wires have varying diameters.
47. The vaso-occlusive device of claim 44, wherein the fine wires are radiopaque.
48. The vaso-occlusive device of claim 38, wherein the mesh-like structure is coated with radiopaque material.
49. The vaso-occlusive device of claim 38, further comprising radiopaque markers coupled to the mesh-like structure.
50. A catheter assembly for occluding an aneurysm having an aneurysmal neck and an aneurysmal inner wall, comprising:
a delivery catheter having a distal end; and
a mesh-like structure detachably coupled to the distal end of the catheter, the mesh-like structure comprising a retainer and an anchor, the retainer configured to be inserted through the aneurysmal neck when in an undeployed state, and configured to expand against a portion of the aneurysmal inner wall surrounding the aneurysmal neck when in a deployed state, wherein a portion of the aneurysmal inner wall is not covered by the mesh-like structure, the anchor configured to expand against a portion of the vessel inner wall adjacent the aneurysmal neck when in a deployed state.
51. The vaso-occlusive device of claim 50, wherein the mesh-like structure further comprises a central tubular element, and the retainer and anchor are formed at opposing ends of the central tubular element.
52. The vaso-occlusive device in claim 50, wherein the retainer and anchor are shaped as flattened disks.
53. The vaso-occlusive device in claim 50, wherein the retainer is shaped as a flared open cup and the anchor is shaped as a flattened disk.
54. The vaso-occlusive device of claim 50, wherein the retainer and anchor are configured to expand by heat activation into the deployed state.
55. The vaso-occlusive device of claim 50, wherein the retainer and anchor are configured to expand into the deployed state when unconstrained.
56. The vaso-occlusive device of claim 50, wherein the mesh-like structure is formed from a plurality of braided fine wires.
57. The vaso-occlusive device of claim 50, wherein the mesh-like structure is composed of a NiTi alloy.
58. The vaso-occlusive device of claim 56, wherein the plurality of fine wires have varying diameters.
59. The vaso-occlusive device of claim 56, wherein the fine wires are radiopaque.
60. The vaso-occlusive device of claim 50, wherein the mesh-like structure is coated with radiopaque material.
61. The vaso-occlusive device of claim 50, further comprising radiopaque markers coupled to the mesh-like structure.
62. A method of occluding an aneurysm with a mesh-like structure, the aneurysm having an aneurysmal neck and an aneurysmal inner wall, the aneurysm residing in a vessel having a vessel inner wall, comprising:
delivering the mesh-like structure to the aneurysm;
inserting a first end of the mesh-like structure through the aneurysmal neck;
expanding the first end of the mesh-like structure against a portion of the aneurysmal inner wall surrounding the aneurysmal neck, wherein a portion of the aneurysmal inner wall is not covered by the mesh-like structure; and
expanding a second end of the mesh-like structure against a portion of the vessel inner wall adjacent the aneurysmal neck to anchor the mesh-like structure.
63. The method of claim 62, wherein the mesh-like structure comprises a central tubular element between the first and second ends, and the method further comprises inserting the central tubular element within the aneurysmal neck.
64. The method of claim 62, wherein the first and second ends of the mesh-like structure are both expanded into flattened disks.
65. The method of claim 62, wherein the first end of the mesh-like structure is expanded into an open cup, and the second end of the mesh-like structure is expanded into a flattened disk.
66. The method of claim 62, wherein the mesh-like structure is heat activated to expand the first and second ends.
67. The method of claim 62, wherein a compressive force is released from the mesh-like structure to expand the first and second ends.
68. The method of claim 62, further comprising introducing a vaso-occlusive agent through the mesh-like structure and into the aneurysm, wherein the vaso-occlusive agent is retained within the aneurysm.
69. The method of claim 68, wherein the vaso-occlusive agent comprises one or more coils.
70. The method of claim 68, wherein the vaso-occlusive agent comprises an embolic agent.
71. The method of claim 62, wherein the mesh-like structure is delivered to the aneurysm with a catheter.
72. The method of claim 71, further comprising releasing the mesh-like structure from the catheter using a method selected from a group consisting of an electrolytically severable method, a retractable sheath method, and a push method.
US10/121,980 2002-04-12 2002-04-12 System and method for retaining vaso-occlusive devices within an aneurysm Abandoned US20030195553A1 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
US10/121,980 US20030195553A1 (en) 2002-04-12 2002-04-12 System and method for retaining vaso-occlusive devices within an aneurysm
JP2003583267A JP4414767B2 (en) 2002-04-12 2003-04-10 Fixation device for vascular occlusion device in aneurysm
ES03721607T ES2331567T3 (en) 2002-04-12 2003-04-10 DEVICES FOR THE RETENTION OF GLASS-OCLUSIVE DEVICES WITHIN AN ANEURISM.
CA2481224A CA2481224C (en) 2002-04-12 2003-04-10 Devices for retaining vaso-occlussive devices within an aneurysm
DE60328765T DE60328765D1 (en) 2002-04-12 2003-04-10 DEVICES FOR HOLDING VASOOKCLUSIVE DEVICES IN ANEURYSMA
PCT/US2003/010997 WO2003086240A1 (en) 2002-04-12 2003-04-10 Devices for retaining vaso-occlussive devices within an aneurysm
EP03721607A EP1494619B1 (en) 2002-04-12 2003-04-10 Devices for retaining vaso-occlussive devices within an aneurysm
AT03721607T ATE439092T1 (en) 2002-04-12 2003-04-10 DEVICES FOR RETAINING VAS-OCCLUSIVE DEVICES IN AN ANEURYSMA
AU2003224913A AU2003224913A1 (en) 2002-04-12 2003-04-10 Devices for retaining vaso-occlussive devices within an aneurysm
US11/617,293 US20070106311A1 (en) 2002-04-12 2006-12-28 System and method for retaining vaso-occlusive devices within an aneurysm
US13/091,608 US9314326B2 (en) 2002-04-12 2011-04-21 System and method for retaining vaso-occlusive devices within an aneurysm

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/121,980 US20030195553A1 (en) 2002-04-12 2002-04-12 System and method for retaining vaso-occlusive devices within an aneurysm

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/617,293 Continuation US20070106311A1 (en) 2002-04-12 2006-12-28 System and method for retaining vaso-occlusive devices within an aneurysm

Publications (1)

Publication Number Publication Date
US20030195553A1 true US20030195553A1 (en) 2003-10-16

Family

ID=28790456

Family Applications (3)

Application Number Title Priority Date Filing Date
US10/121,980 Abandoned US20030195553A1 (en) 2002-04-12 2002-04-12 System and method for retaining vaso-occlusive devices within an aneurysm
US11/617,293 Abandoned US20070106311A1 (en) 2002-04-12 2006-12-28 System and method for retaining vaso-occlusive devices within an aneurysm
US13/091,608 Active 2024-12-10 US9314326B2 (en) 2002-04-12 2011-04-21 System and method for retaining vaso-occlusive devices within an aneurysm

Family Applications After (2)

Application Number Title Priority Date Filing Date
US11/617,293 Abandoned US20070106311A1 (en) 2002-04-12 2006-12-28 System and method for retaining vaso-occlusive devices within an aneurysm
US13/091,608 Active 2024-12-10 US9314326B2 (en) 2002-04-12 2011-04-21 System and method for retaining vaso-occlusive devices within an aneurysm

Country Status (9)

Country Link
US (3) US20030195553A1 (en)
EP (1) EP1494619B1 (en)
JP (1) JP4414767B2 (en)
AT (1) ATE439092T1 (en)
AU (1) AU2003224913A1 (en)
CA (1) CA2481224C (en)
DE (1) DE60328765D1 (en)
ES (1) ES2331567T3 (en)
WO (1) WO2003086240A1 (en)

Cited By (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050049681A1 (en) * 2003-05-19 2005-03-03 Secant Medical, Llc Tissue distention device and related methods for therapeutic intervention
US20050283183A1 (en) * 2004-06-21 2005-12-22 Tri Tran Expanding vaso-occlusive device
US20060064151A1 (en) * 2004-09-22 2006-03-23 Guterman Lee R Cranial aneurysm treatment arrangement
US20060155323A1 (en) * 2005-01-07 2006-07-13 Porter Stephen C Intra-aneurysm devices
US20060247680A1 (en) * 2004-04-08 2006-11-02 Aga Medical Corporation Flanged occlusion devices and methods
US20070088387A1 (en) * 2005-10-19 2007-04-19 Pulsar Vascular, Inc. Implantable aneurysm closure systems and methods
US20070233174A1 (en) * 2005-04-01 2007-10-04 Gordon Hocking Trapping Filter for Blood Vessel
US20070270902A1 (en) * 2004-09-17 2007-11-22 Slazas Robert R Thin Film Metallic Devices for Plugging Aneurysms or Vessels
WO2007140797A1 (en) * 2006-06-02 2007-12-13 Occlutech Gmbh Occlusion instrument for closing a cardiac auricle
EP1901665A2 (en) * 2005-07-11 2008-03-26 USGI Medical Inc Compressible tissue anchor assemblies
US20080200945A1 (en) * 2004-03-19 2008-08-21 Aga Medical Corporation Device for occluding vascular defects
US20080221600A1 (en) * 2006-08-17 2008-09-11 Dieck Martin S Isolation devices for the treatment of aneurysms
US20090062841A1 (en) * 2004-03-19 2009-03-05 Aga Medical Corporation Device for occluding vascular defects
US20110046719A1 (en) * 2004-06-03 2011-02-24 Noureddine Frid Luminal Endoprosthesis For the Occlusion of an Aneurysm and Method of Manufacturing Such an Endoprosthesis
US8142456B2 (en) 2008-04-21 2012-03-27 Nfocus Neuromedical, Inc. Braid-ball embolic devices
US20120271337A1 (en) * 2007-04-16 2012-10-25 Hans-Reiner Figulla Occluder For Occluding an Atrial Appendage and Production Process Therefor
WO2012163880A1 (en) * 2011-05-31 2012-12-06 Acandis Gmbh & Co. Kg Medical implant for arrangement within a hollow body, in particular an aneurysm, and method for producing a medical implant
US20130012979A1 (en) * 2004-03-19 2013-01-10 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body
US8388650B2 (en) 2008-09-05 2013-03-05 Pulsar Vascular, Inc. Systems and methods for supporting or occluding a physiological opening or cavity
US8425548B2 (en) 2010-07-01 2013-04-23 Aneaclose LLC Occluding member expansion and then stent expansion for aneurysm treatment
AU2010249161B2 (en) * 2004-01-22 2013-05-16 Microvention, Inc. Aneurysm treatment device and method of use
US8551132B2 (en) 2005-10-19 2013-10-08 Pulsar Vascular, Inc. Methods and systems for endovascularly clipping and repairing lumen and tissue defects
US8636760B2 (en) 2009-04-20 2014-01-28 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US8747453B2 (en) 2008-02-18 2014-06-10 Aga Medical Corporation Stent/stent graft for reinforcement of vascular abnormalities and associated method
US8777974B2 (en) * 2004-03-19 2014-07-15 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects
WO2014128313A1 (en) * 2013-02-21 2014-08-28 Castaño Duque Carlos Device for supporting and positioning occlusive elements
WO2014137467A1 (en) * 2013-03-05 2014-09-12 Aga Medical Corporation Medical device for treating a target site
US20140350588A1 (en) * 2011-11-09 2014-11-27 Easynotes Ltd. Obstruction device
US8906057B2 (en) 2010-01-04 2014-12-09 Aneuclose Llc Aneurysm embolization by rotational accumulation of mass
US8926681B2 (en) 2010-01-28 2015-01-06 Covidien Lp Vascular remodeling device
US8974487B2 (en) 2008-05-01 2015-03-10 Aneuclose Llc Aneurysm occlusion device
JP2015083139A (en) * 2005-10-19 2015-04-30 パルサー バスキュラー インコーポレイテッド Method and system for endovascularly clipping and repairing lumen and tissue defect
US9023094B2 (en) 2007-06-25 2015-05-05 Microvention, Inc. Self-expanding prosthesis
US9060886B2 (en) 2011-09-29 2015-06-23 Covidien Lp Vascular remodeling device
US9089332B2 (en) 2011-03-25 2015-07-28 Covidien Lp Vascular remodeling device
US9095343B2 (en) 2005-05-25 2015-08-04 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US9095342B2 (en) 2009-11-09 2015-08-04 Covidien Lp Braid ball embolic device features
US9119625B2 (en) 2011-10-05 2015-09-01 Pulsar Vascular, Inc. Devices, systems and methods for enclosing an anatomical opening
US9138232B2 (en) 2011-05-24 2015-09-22 Aneuclose Llc Aneurysm occlusion by rotational dispensation of mass
US9155647B2 (en) 2012-07-18 2015-10-13 Covidien Lp Methods and apparatus for luminal stenting
WO2015166013A1 (en) 2014-04-30 2015-11-05 Cerus Endovascular Limited Occlusion device
US9179918B2 (en) 2008-07-22 2015-11-10 Covidien Lp Vascular remodeling device
US9186267B2 (en) 2012-10-31 2015-11-17 Covidien Lp Wing bifurcation reconstruction device
CN105105812A (en) * 2015-09-18 2015-12-02 王奎重 Intracranial aneurysm interventional embolization treatment device
US9204983B2 (en) 2005-05-25 2015-12-08 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US9259229B2 (en) 2012-05-10 2016-02-16 Pulsar Vascular, Inc. Systems and methods for enclosing an anatomical opening, including coil-tipped aneurysm devices
US9277924B2 (en) 2009-09-04 2016-03-08 Pulsar Vascular, Inc. Systems and methods for enclosing an anatomical opening
US9295571B2 (en) 2013-01-17 2016-03-29 Covidien Lp Methods and apparatus for luminal stenting
US9314248B2 (en) 2012-11-06 2016-04-19 Covidien Lp Multi-pivot thrombectomy device
US9351859B2 (en) 2010-12-06 2016-05-31 Covidien Lp Vascular remodeling device
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
US9393022B2 (en) 2011-02-11 2016-07-19 Covidien Lp Two-stage deployment aneurysm embolization devices
US20160213459A1 (en) * 2013-03-15 2016-07-28 Insera Therapeutics, Inc. Vascular treatment devices and methods
WO2016161344A1 (en) * 2015-04-01 2016-10-06 Boston Scientific Scimed, Inc. Systems and methods for delivery of gel embolics
US9463105B2 (en) 2013-03-14 2016-10-11 Covidien Lp Methods and apparatus for luminal stenting
US9468442B2 (en) 2010-01-28 2016-10-18 Covidien Lp Vascular remodeling device
US9675482B2 (en) 2008-05-13 2017-06-13 Covidien Lp Braid implant delivery systems
US20170252045A1 (en) * 2013-03-13 2017-09-07 Lawrence Livermore National Security, Llc Shape-memory polymer foam device for treating aneurysms
WO2017153603A1 (en) 2016-03-11 2017-09-14 Cerus Endovascular Limited Occlusion device
WO2017201316A1 (en) * 2016-05-18 2017-11-23 Microvention, Inc. Embolic containment
US10004510B2 (en) 2011-06-03 2018-06-26 Pulsar Vascular, Inc. Systems and methods for enclosing an anatomical opening, including shock absorbing aneurysm devices
US10028745B2 (en) 2011-03-30 2018-07-24 Noha, Llc Advanced endovascular clip and method of using same
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
US20180242979A1 (en) * 2017-02-23 2018-08-30 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US20180333158A1 (en) * 2015-02-25 2018-11-22 Galaxy Therapeutics, Llc System for and method of treating aneurysms
US10327781B2 (en) 2012-11-13 2019-06-25 Covidien Lp Occlusive devices
US20190223876A1 (en) * 2018-01-19 2019-07-25 Galaxy Therapeutics, Llc System for and method of treating aneurysms
US10390926B2 (en) 2013-07-29 2019-08-27 Insera Therapeutics, Inc. Aspiration devices and methods
US10478194B2 (en) 2015-09-23 2019-11-19 Covidien Lp Occlusive devices
US10555738B2 (en) 2016-05-18 2020-02-11 Microvention, Inc. Embolic containment
EP2228020B2 (en) 2004-03-19 2020-03-18 AGA Medical Corporation Multi-layer braided structures for occluding vascular defects
US20200100795A1 (en) * 2008-05-01 2020-04-02 Aneuclose Llc "Bowl-of-Spaghetti" Type Intrasacular Aneurysm Occlusion Device
CN111031938A (en) * 2017-08-22 2020-04-17 柯惠有限合伙公司 Devices, systems, and methods for treating vascular defects
US10624647B2 (en) 2011-06-03 2020-04-21 Pulsar Vascular, Inc. Aneurysm devices with additional anchoring mechanisms and associated systems and methods
US10653425B1 (en) 2019-05-21 2020-05-19 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
US10736758B2 (en) 2013-03-15 2020-08-11 Covidien Occlusive device
US10856880B1 (en) 2019-05-25 2020-12-08 Galaxy Therapeutics, Inc. Systems and methods for treating aneurysms
US10905430B2 (en) 2018-01-24 2021-02-02 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US10939915B2 (en) 2018-05-31 2021-03-09 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11058430B2 (en) * 2018-05-25 2021-07-13 DePuy Synthes Products, Inc. Aneurysm device and delivery system
CN113180882A (en) * 2016-06-21 2021-07-30 内流医疗有限公司 Device and kit for treating vascular malformed portions
US11076861B2 (en) * 2018-10-12 2021-08-03 DePuy Synthes Products, Inc. Folded aneurysm treatment device and delivery method
US11076860B2 (en) 2014-03-31 2021-08-03 DePuy Synthes Products, Inc. Aneurysm occlusion device
WO2021130064A3 (en) * 2019-12-23 2021-08-19 Phenox Gmbh Implant for treating aneurysms
US11123077B2 (en) 2018-09-25 2021-09-21 DePuy Synthes Products, Inc. Intrasaccular device positioning and deployment system
US11134953B2 (en) 2019-02-06 2021-10-05 DePuy Synthes Products, Inc. Adhesive cover occluding device for aneurysm treatment
US11154302B2 (en) 2014-03-31 2021-10-26 DePuy Synthes Products, Inc. Aneurysm occlusion device
US11272939B2 (en) * 2018-12-18 2022-03-15 DePuy Synthes Products, Inc. Intrasaccular flow diverter for treating cerebral aneurysms
US11278292B2 (en) 2019-05-21 2022-03-22 DePuy Synthes Products, Inc. Inverting braided aneurysm treatment system and method
US11284903B2 (en) 2011-03-30 2022-03-29 Hesham Morsi Advanced endovascular clip and method of using same
CN114391910A (en) * 2014-12-31 2022-04-26 先健科技(深圳)有限公司 Left auricle plugging device
US11337706B2 (en) 2019-03-27 2022-05-24 DePuy Synthes Products, Inc. Aneurysm treatment device
US11406392B2 (en) 2018-12-12 2022-08-09 DePuy Synthes Products, Inc. Aneurysm occluding device for use with coagulating agents
US11406404B2 (en) 2020-02-20 2022-08-09 Cerus Endovascular Limited Clot removal distal protection methods
US11413046B2 (en) 2019-05-21 2022-08-16 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device
US11457926B2 (en) 2019-12-18 2022-10-04 DePuy Synthes Products, Inc. Implant having an intrasaccular section and intravascular section
US11471162B2 (en) 2015-12-07 2022-10-18 Cerus Endovascular Limited Occlusion device
US11497504B2 (en) 2019-05-21 2022-11-15 DePuy Synthes Products, Inc. Aneurysm treatment with pushable implanted braid
US11583288B2 (en) 2018-08-08 2023-02-21 DePuy Synthes Products, Inc. Delivery of embolic braid
US11596412B2 (en) 2018-05-25 2023-03-07 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11602350B2 (en) 2019-12-05 2023-03-14 DePuy Synthes Products, Inc. Intrasaccular inverting braid with highly flexible fill material
US11607226B2 (en) 2019-05-21 2023-03-21 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device with corrugations
US11633818B2 (en) 2019-11-04 2023-04-25 Covidien Lp Devices, systems, and methods for treatment of intracranial aneurysms
US11672542B2 (en) 2019-05-21 2023-06-13 DePuy Synthes Products, Inc. Aneurysm treatment with pushable ball segment
CN116687496A (en) * 2023-08-04 2023-09-05 北京久事神康医疗科技有限公司 Plug device with net disc
US11812971B2 (en) 2017-08-21 2023-11-14 Cerus Endovascular Limited Occlusion device

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE502004008712D1 (en) 2004-09-22 2009-01-29 Dendron Gmbh MEDICAL IMPLANT
US8845676B2 (en) 2004-09-22 2014-09-30 Micro Therapeutics Micro-spiral implantation device
WO2007006139A1 (en) * 2005-07-12 2007-01-18 Smart Biotech Inc. Aneurysm occlusion device
KR20090008347A (en) 2006-04-17 2009-01-21 마이크로 테라퓨틱스 인코포레이티드 System and method for mechanically positioning intravascular implants
WO2008063455A1 (en) * 2006-11-13 2008-05-29 Hines Richard A Over-the wire exclusion device and system for delivery
JP5249249B2 (en) 2007-03-13 2013-07-31 コヴィディエン リミテッド パートナーシップ Implant including a coil and a stretch resistant member
US20090227938A1 (en) * 2008-03-05 2009-09-10 Insitu Therapeutics, Inc. Wound Closure Devices, Methods of Use, and Kits
US11484322B2 (en) 2018-01-03 2022-11-01 Aneuclose Llc Aneurysm neck bridge with a closeable opening or lumen through which embolic material is inserted into the aneurysm sac
US11471163B2 (en) 2008-05-01 2022-10-18 Aneuclose Llc Intrasaccular aneurysm occlusion device with net or mesh expanded by string-of-pearls embolies
US11464518B2 (en) 2008-05-01 2022-10-11 Aneuclose Llc Proximal concave neck bridge with central lumen and distal net for occluding cerebral aneurysms
US20100131002A1 (en) * 2008-11-24 2010-05-27 Connor Robert A Stent with a net layer to embolize and aneurysm
US20110034941A1 (en) * 2009-08-10 2011-02-10 Joseph Iraci Surgical Instrument for Hernia Repair and Method
WO2011098633A1 (en) * 2010-02-12 2011-08-18 Vasuclip, S.L. Device for aneurysm occlusion and a treatment method
US9579104B2 (en) 2011-11-30 2017-02-28 Covidien Lp Positioning and detaching implants
US9011480B2 (en) 2012-01-20 2015-04-21 Covidien Lp Aneurysm treatment coils
US9687245B2 (en) 2012-03-23 2017-06-27 Covidien Lp Occlusive devices and methods of use
US20150133989A1 (en) * 2012-04-20 2015-05-14 Inceptus Medical, Llc Expandable occlusion devices and methods of use
US8690907B1 (en) 2013-03-15 2014-04-08 Insera Therapeutics, Inc. Vascular treatment methods
US8715314B1 (en) 2013-03-15 2014-05-06 Insera Therapeutics, Inc. Vascular treatment measurement methods
US8679150B1 (en) 2013-03-15 2014-03-25 Insera Therapeutics, Inc. Shape-set textile structure based mechanical thrombectomy methods
US20150018860A1 (en) 2013-07-12 2015-01-15 Inceptus Medical, Llc Methods and apparatus for treating small vessel thromboembolisms
US9713475B2 (en) 2014-04-18 2017-07-25 Covidien Lp Embolic medical devices
US9918718B2 (en) 2014-08-08 2018-03-20 DePuy Synthes Products, Inc. Embolic coil delivery system with retractable mechanical release mechanism
US9962146B2 (en) 2015-01-20 2018-05-08 Neurogami Medical, Inc. Micrograft for the treatment of intracranial aneurysms and method for use
US11484319B2 (en) 2015-01-20 2022-11-01 Neurogami Medical, Inc. Delivery system for micrograft for treating intracranial aneurysms
US10925611B2 (en) 2015-01-20 2021-02-23 Neurogami Medical, Inc. Packaging for surgical implant
US10857012B2 (en) 2015-01-20 2020-12-08 Neurogami Medical, Inc. Vascular implant
US10736730B2 (en) 2015-01-20 2020-08-11 Neurogami Medical, Inc. Vascular implant
DE102015104785A1 (en) * 2015-03-27 2016-09-29 Pfm Medical Ag Device for closing a cardiac ear
WO2017106567A1 (en) * 2015-12-15 2017-06-22 Nsvascular, Inc. Intrasaccular thin-film flow diverters and related methods
KR20190008520A (en) 2016-02-10 2019-01-24 마이크로벤션, 인코포레이티드 Devices for vascular occlusion
US10420563B2 (en) 2016-07-08 2019-09-24 Neurogami Medical, Inc. Delivery system insertable through body lumen
US20180049859A1 (en) * 2016-08-16 2018-02-22 Spartan Micro, Inc. Intravascular flow diversion devices
US9994980B2 (en) 2016-10-14 2018-06-12 Inceptus Medical, Llc Braiding machine and methods of use
WO2018073830A2 (en) * 2016-10-21 2018-04-26 Javelin Medical Ltd. Systems, methods and devices for embolic protection
EP3554391A4 (en) 2017-02-24 2020-09-16 Inceptus Medical LLC Vascular occlusion devices and methods
US11812968B2 (en) * 2017-05-10 2023-11-14 Lifetech Scientific (Shenzhen) Co. Ltd. Left atrial appendage occluder
US11885051B2 (en) 2017-10-14 2024-01-30 Inceptus Medical, Llc Braiding machine and methods of use
US10806462B2 (en) 2017-12-21 2020-10-20 DePuy Synthes Products, Inc. Implantable medical device detachment system with split tube and cylindrical coupling
US10751065B2 (en) 2017-12-22 2020-08-25 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US10716574B2 (en) 2017-12-22 2020-07-21 DePuy Synthes Products, Inc. Aneurysm device and delivery method
US11147562B2 (en) 2018-12-12 2021-10-19 DePuy Synthes Products, Inc. Systems and methods for embolic implant detachment
US11253265B2 (en) 2019-06-18 2022-02-22 DePuy Synthes Products, Inc. Pull wire detachment for intravascular devices
US11207494B2 (en) 2019-07-03 2021-12-28 DePuy Synthes Products, Inc. Medical device delivery member with flexible stretch resistant distal portion
US11426174B2 (en) 2019-10-03 2022-08-30 DePuy Synthes Products, Inc. Medical device delivery member with flexible stretch resistant mechanical release
US11439403B2 (en) 2019-09-17 2022-09-13 DePuy Synthes Products, Inc. Embolic coil proximal connecting element and stretch resistant fiber
US11376013B2 (en) 2019-11-18 2022-07-05 DePuy Synthes Products, Inc. Implant delivery system with braid cup formation
US11457922B2 (en) 2020-01-22 2022-10-04 DePuy Synthes Products, Inc. Medical device delivery member with flexible stretch resistant distal portion
US11432822B2 (en) 2020-02-14 2022-09-06 DePuy Synthes Products, Inc. Intravascular implant deployment system
JP7427202B2 (en) 2021-05-28 2024-02-05 有限会社ウサミナノテクノロジー Aneurysm neck embolization member and method for manufacturing the aneurysm neck embolization member
US11844490B2 (en) 2021-12-30 2023-12-19 DePuy Synthes Products, Inc. Suture linkage for inhibiting premature embolic implant deployment

Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739768A (en) * 1986-06-02 1988-04-26 Target Therapeutics Catheter for guide-wire tracking
US4994069A (en) * 1988-11-02 1991-02-19 Target Therapeutics Vaso-occlusion coil and method
US5122136A (en) * 1990-03-13 1992-06-16 The Regents Of The University Of California Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5250071A (en) * 1992-09-22 1993-10-05 Target Therapeutics, Inc. Detachable embolic coil assembly using interlocking clasps and method of use
US5261916A (en) * 1991-12-12 1993-11-16 Target Therapeutics Detachable pusher-vasoocclusive coil assembly with interlocking ball and keyway coupling
US5354295A (en) * 1990-03-13 1994-10-11 Target Therapeutics, Inc. In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5928260A (en) * 1997-07-10 1999-07-27 Scimed Life Systems, Inc. Removable occlusion system for aneurysm neck
US5944750A (en) * 1997-06-30 1999-08-31 Eva Corporation Method and apparatus for the surgical repair of aneurysms
US6063070A (en) * 1997-08-05 2000-05-16 Target Therapeutics, Inc. Detachable aneurysm neck bridge (II)
US6077281A (en) * 1992-01-21 2000-06-20 Regents Of The University Of Minnesota Septal defect closure device
US6080182A (en) * 1996-12-20 2000-06-27 Gore Enterprise Holdings, Inc. Self-expanding defect closure device and method of making and using
US6086577A (en) * 1997-08-13 2000-07-11 Scimed Life Systems, Inc. Detachable aneurysm neck bridge (III)
US6168622B1 (en) * 1996-01-24 2001-01-02 Microvena Corporation Method and apparatus for occluding aneurysms
US6346117B1 (en) * 2000-03-02 2002-02-12 Prodesco, Inc. Bag for use in the intravascular treatment of saccular aneurysms
US6375668B1 (en) * 1999-06-02 2002-04-23 Hanson S. Gifford Devices and methods for treating vascular malformations

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US634617A (en) * 1898-09-06 1899-10-10 Charles H Hansen Brush.
US4830003A (en) * 1988-06-17 1989-05-16 Wolff Rodney G Compressive stent and delivery system
US4991602A (en) * 1989-06-27 1991-02-12 Flexmedics Corporation Flexible guide wire with safety tip
US5527338A (en) * 1992-09-02 1996-06-18 Board Of Regents, The University Of Texas System Intravascular device
US6123715A (en) 1994-07-08 2000-09-26 Amplatz; Curtis Method of forming medical devices; intravascular occlusion devices
US5725552A (en) 1994-07-08 1998-03-10 Aga Medical Corporation Percutaneous catheter directed intravascular occlusion devices
WO1996001591A1 (en) * 1994-07-08 1996-01-25 Microvena Corporation Method of forming medical devices; intravascular occlusion devices
US8790363B2 (en) 1995-04-20 2014-07-29 DePuy Synthes Products, LLC Three dimensional, low friction vasoocclusive coil, and method of manufacture
US5944730A (en) * 1997-05-19 1999-08-31 Cardio Medical Solutions, Inc. Device and method for assisting end-to-side anastomosis
US5951599A (en) 1997-07-09 1999-09-14 Scimed Life Systems, Inc. Occlusion system for endovascular treatment of an aneurysm
GB9715241D0 (en) 1997-07-18 1997-09-24 Jeffree Martin A Device for treating aneurysms
EP1006890B1 (en) 1997-08-04 2006-09-20 Boston Scientific Limited Occlusion system for aneurysm repair
US6511468B1 (en) 1997-10-17 2003-01-28 Micro Therapeutics, Inc. Device and method for controlling injection of liquid embolic composition
US6159165A (en) 1997-12-05 2000-12-12 Micrus Corporation Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand
US5944738A (en) * 1998-02-06 1999-08-31 Aga Medical Corporation Percutaneous catheter directed constricting occlusion device
ATE454098T1 (en) 1998-02-10 2010-01-15 Artemis Medical Inc OCCLUSION, ANCHORING, CHIPING OR POWER CONTROL DEVICE
US6168615B1 (en) 1998-05-04 2001-01-02 Micrus Corporation Method and apparatus for occlusion and reinforcement of aneurysms
US6093199A (en) 1998-08-05 2000-07-25 Endovascular Technologies, Inc. Intra-luminal device for treatment of body cavities and lumens and method of use
DE69936869T2 (en) 1998-09-04 2008-05-15 Boston Scientific Ltd., St. Michael REMOVABLE SYSTEM FOR CLOSING AN ANEURYSMAS NECK
US7044134B2 (en) * 1999-11-08 2006-05-16 Ev3 Sunnyvale, Inc Method of implanting a device in the left atrial appendage
US6613074B1 (en) 1999-03-10 2003-09-02 Cordis Corporation Endovascular aneurysm embolization device
US6238403B1 (en) 1999-10-04 2001-05-29 Microvention, Inc. Filamentous embolic device with expansible elements
US6551303B1 (en) * 1999-10-27 2003-04-22 Atritech, Inc. Barrier device for ostium of left atrial appendage
US6391037B1 (en) 2000-03-02 2002-05-21 Prodesco, Inc. Bag for use in the intravascular treatment of saccular aneurysms
US6454780B1 (en) 2001-06-21 2002-09-24 Scimed Life Systems, Inc. Aneurysm neck obstruction device
US6811560B2 (en) 2001-09-20 2004-11-02 Cordis Neurovascular, Inc. Stent aneurysm embolization method and device
US6638257B2 (en) 2002-03-01 2003-10-28 Aga Medical Corporation Intravascular flow restrictor
US8398670B2 (en) 2004-03-19 2013-03-19 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body
US8313505B2 (en) 2004-03-19 2012-11-20 Aga Medical Corporation Device for occluding vascular defects
US8777974B2 (en) 2004-03-19 2014-07-15 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects
AU2005232562B2 (en) 2004-04-08 2009-05-07 St. Jude Medical, Cardiology Division, Inc. Flange occlusion devices and methods
US8444668B2 (en) 2004-09-17 2013-05-21 DePuy Synthes Products, LLC Expandable vascular occlusion device
WO2006034153A2 (en) * 2004-09-17 2006-03-30 Cordis Neurovascular, Inc. Thin film metallic devices for plugging aneurysms or vessels
KR20090008347A (en) 2006-04-17 2009-01-21 마이크로 테라퓨틱스 인코포레이티드 System and method for mechanically positioning intravascular implants
US8034061B2 (en) 2007-07-12 2011-10-11 Aga Medical Corporation Percutaneous catheter directed intravascular occlusion devices
US8361138B2 (en) 2007-07-25 2013-01-29 Aga Medical Corporation Braided occlusion device having repeating expanded volume segments separated by articulation segments
US20090112251A1 (en) 2007-07-25 2009-04-30 Aga Medical Corporation Braided occlusion device having repeating expanded volume segments separated by articulation segments
WO2009036219A1 (en) 2007-09-11 2009-03-19 Nfocus Neuromedical Inc. Aneurysm cover device for embolic delivery and retention
US9743918B2 (en) 2008-01-18 2017-08-29 St. Jude Medical, Cardiology Division, Inc. Percutaneous catheter directed intravascular occlusion device
JP5610542B2 (en) 2008-04-21 2014-10-22 コヴィディエン リミテッド パートナーシップ Blade ball embolization device and delivery system
US9232992B2 (en) 2008-07-24 2016-01-12 Aga Medical Corporation Multi-layered medical device for treating a target site and associated method
US9427304B2 (en) 2008-10-27 2016-08-30 St. Jude Medical, Cardiology Division, Inc. Multi-layer device with gap for treating a target site and associated method
US8940015B2 (en) 2008-11-11 2015-01-27 Aga Medical Corporation Asymmetrical medical devices for treating a target site and associated method
US8906057B2 (en) * 2010-01-04 2014-12-09 Aneuclose Llc Aneurysm embolization by rotational accumulation of mass
US8821529B2 (en) 2011-03-25 2014-09-02 Aga Medical Corporation Device and method for occluding a septal defect
US8511214B2 (en) 2011-04-21 2013-08-20 Aga Medical Corporation Tubular structure and method for making the same
US8764787B2 (en) 2011-06-17 2014-07-01 Aga Medical Corporation Occlusion device and associated deployment method
US8758389B2 (en) 2011-11-18 2014-06-24 Aga Medical Corporation Devices and methods for occluding abnormal openings in a patient's vasculature
US9113890B2 (en) 2012-02-06 2015-08-25 Aga Medical Corporation Devices and methods for occluding vascular abnormalities
US9687245B2 (en) 2012-03-23 2017-06-27 Covidien Lp Occlusive devices and methods of use
KR20150084959A (en) 2012-11-13 2015-07-22 코비디엔 엘피 Occlusive devices
US10973523B2 (en) 2013-03-08 2021-04-13 Aga Medical Corporation Medical device for treating a target site

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739768B1 (en) * 1986-06-02 1994-11-15 Target Therapeutics Inc Catheter for guide-wire tracking
US4739768B2 (en) * 1986-06-02 1995-10-24 Target Therapeutics Inc Catheter for guide-wire tracking
US4739768A (en) * 1986-06-02 1988-04-26 Target Therapeutics Catheter for guide-wire tracking
US4994069A (en) * 1988-11-02 1991-02-19 Target Therapeutics Vaso-occlusion coil and method
US5122136A (en) * 1990-03-13 1992-06-16 The Regents Of The University Of California Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5354295A (en) * 1990-03-13 1994-10-11 Target Therapeutics, Inc. In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5261916A (en) * 1991-12-12 1993-11-16 Target Therapeutics Detachable pusher-vasoocclusive coil assembly with interlocking ball and keyway coupling
US6077281A (en) * 1992-01-21 2000-06-20 Regents Of The University Of Minnesota Septal defect closure device
US5250071A (en) * 1992-09-22 1993-10-05 Target Therapeutics, Inc. Detachable embolic coil assembly using interlocking clasps and method of use
US6168622B1 (en) * 1996-01-24 2001-01-02 Microvena Corporation Method and apparatus for occluding aneurysms
US6080182A (en) * 1996-12-20 2000-06-27 Gore Enterprise Holdings, Inc. Self-expanding defect closure device and method of making and using
US5944750A (en) * 1997-06-30 1999-08-31 Eva Corporation Method and apparatus for the surgical repair of aneurysms
US5928260A (en) * 1997-07-10 1999-07-27 Scimed Life Systems, Inc. Removable occlusion system for aneurysm neck
US6063070A (en) * 1997-08-05 2000-05-16 Target Therapeutics, Inc. Detachable aneurysm neck bridge (II)
US6086577A (en) * 1997-08-13 2000-07-11 Scimed Life Systems, Inc. Detachable aneurysm neck bridge (III)
US6375668B1 (en) * 1999-06-02 2002-04-23 Hanson S. Gifford Devices and methods for treating vascular malformations
US6346117B1 (en) * 2000-03-02 2002-02-12 Prodesco, Inc. Bag for use in the intravascular treatment of saccular aneurysms

Cited By (223)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7122043B2 (en) 2003-05-19 2006-10-17 Stout Medical Group, L.P. Tissue distention device and related methods for therapeutic intervention
US7648532B2 (en) 2003-05-19 2010-01-19 Septrx, Inc. Tissue distention device and related methods for therapeutic intervention
US20050049681A1 (en) * 2003-05-19 2005-03-03 Secant Medical, Llc Tissue distention device and related methods for therapeutic intervention
US8758395B2 (en) 2003-05-19 2014-06-24 Septrx, Inc. Embolic filtering method and apparatus
US20060178694A1 (en) * 2003-05-19 2006-08-10 Secant Medical, Llc Tissue distention device and related methods for therapeutic intervention
AU2010249161B2 (en) * 2004-01-22 2013-05-16 Microvention, Inc. Aneurysm treatment device and method of use
US11134933B2 (en) 2004-03-19 2021-10-05 St. Jude Medical, Cardiology Division, Inc. Multi-layer braided structures for occluding vascular defects
US20080200945A1 (en) * 2004-03-19 2008-08-21 Aga Medical Corporation Device for occluding vascular defects
US9445799B2 (en) 2004-03-19 2016-09-20 St. Jude Medical, Cardiology Division, Inc. Multi-layer braided structures for occluding vascular defects
US20130012979A1 (en) * 2004-03-19 2013-01-10 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body
US8777974B2 (en) * 2004-03-19 2014-07-15 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects
US9445798B2 (en) 2004-03-19 2016-09-20 St. Jude Medical, Cardiology Division, Inc. Multi-layer braided structures for occluding vascular defects
US10624619B2 (en) 2004-03-19 2020-04-21 St. Jude Medical, Cardiology Division, Inc. Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body
US8398670B2 (en) 2004-03-19 2013-03-19 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body
US9877710B2 (en) * 2004-03-19 2018-01-30 St. Jude Medical, Cardiology Division, Inc. Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body
US20090062841A1 (en) * 2004-03-19 2009-03-05 Aga Medical Corporation Device for occluding vascular defects
US9039724B2 (en) * 2004-03-19 2015-05-26 Aga Medical Corporation Device for occluding vascular defects
EP2228020B2 (en) 2004-03-19 2020-03-18 AGA Medical Corporation Multi-layer braided structures for occluding vascular defects
US20150133994A1 (en) * 2004-03-19 2015-05-14 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects
US8313505B2 (en) 2004-03-19 2012-11-20 Aga Medical Corporation Device for occluding vascular defects
EP2856949B2 (en) 2004-04-08 2019-09-11 Aga Medical Corporation Flanged occlusion devices
US11839379B2 (en) * 2004-04-08 2023-12-12 St. Jude Medical, Cardiology Division, Inc. Flanged occlusion devices and methods
US9743932B2 (en) * 2004-04-08 2017-08-29 St. Jude Medical, Cardiology Division, Inc. Flanged occlusion devices and methods
EP2856949B1 (en) 2004-04-08 2015-10-07 Aga Medical Corporation Flanged occlusion devices
US20210275183A1 (en) * 2004-04-08 2021-09-09 St. Jude Medical, Cardiology Division, Inc. Flanged occlusion devices and methods
US20060247680A1 (en) * 2004-04-08 2006-11-02 Aga Medical Corporation Flanged occlusion devices and methods
US10231737B2 (en) 2004-04-08 2019-03-19 St. Jude Medical, Cardiology Division, Inc. Flanged occlusion devices and methods
US11045202B2 (en) * 2004-04-08 2021-06-29 St. Jude Medical, Cardiology Division, Inc. Flanged occlusion devices and methods
US20110046719A1 (en) * 2004-06-03 2011-02-24 Noureddine Frid Luminal Endoprosthesis For the Occlusion of an Aneurysm and Method of Manufacturing Such an Endoprosthesis
US8715338B2 (en) * 2004-06-03 2014-05-06 Noureddine Frid Luminal endoprosthesis for the occlusion of an aneurysm and method of manufacturing such an endoprosthesis
US7749242B2 (en) * 2004-06-21 2010-07-06 Boston Scientific Scimed, Inc. Expanding vaso-occlusive device
US20050283183A1 (en) * 2004-06-21 2005-12-22 Tri Tran Expanding vaso-occlusive device
US8486101B2 (en) 2004-06-21 2013-07-16 Stryker Corporation Expanding vaso-occlusive device
US20100228278A1 (en) * 2004-06-21 2010-09-09 Boston Scientific Scimed, Inc. Expanding vaso-occlusive device
US20070270902A1 (en) * 2004-09-17 2007-11-22 Slazas Robert R Thin Film Metallic Devices for Plugging Aneurysms or Vessels
US20060064151A1 (en) * 2004-09-22 2006-03-23 Guterman Lee R Cranial aneurysm treatment arrangement
WO2006052322A2 (en) * 2004-09-22 2006-05-18 Guterman Lee R Cranial aneurysm treatment arrangement
WO2006052322A3 (en) * 2004-09-22 2009-04-09 Lee R Guterman Cranial aneurysm treatment arrangement
US10265075B2 (en) * 2005-01-07 2019-04-23 Stryker Corporation Intra-aneurysm devices
US20130325053A1 (en) * 2005-01-07 2013-12-05 Stryker Nv Operations Limited Intra-aneurysm devices
US20060155323A1 (en) * 2005-01-07 2006-07-13 Porter Stephen C Intra-aneurysm devices
US20230015848A1 (en) * 2005-01-07 2023-01-19 Stryker Corporation Intra-Aneurysm Devices
US20070233174A1 (en) * 2005-04-01 2007-10-04 Gordon Hocking Trapping Filter for Blood Vessel
US9381104B2 (en) 2005-05-25 2016-07-05 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US9095343B2 (en) 2005-05-25 2015-08-04 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US10322018B2 (en) 2005-05-25 2019-06-18 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US9204983B2 (en) 2005-05-25 2015-12-08 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US9198666B2 (en) 2005-05-25 2015-12-01 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US10064747B2 (en) 2005-05-25 2018-09-04 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
EP1901665A4 (en) * 2005-07-11 2014-01-08 Usgi Medical Inc Compressible tissue anchor assemblies
EP1901665A2 (en) * 2005-07-11 2008-03-26 USGI Medical Inc Compressible tissue anchor assemblies
US8545530B2 (en) * 2005-10-19 2013-10-01 Pulsar Vascular, Inc. Implantable aneurysm closure systems and methods
US8551132B2 (en) 2005-10-19 2013-10-08 Pulsar Vascular, Inc. Methods and systems for endovascularly clipping and repairing lumen and tissue defects
US9510835B2 (en) 2005-10-19 2016-12-06 Pulsar Vascular, Inc. Methods and systems for endovascularly clipping and repairing lumen and tissue defects
JP2015083139A (en) * 2005-10-19 2015-04-30 パルサー バスキュラー インコーポレイテッド Method and system for endovascularly clipping and repairing lumen and tissue defect
US20070088387A1 (en) * 2005-10-19 2007-04-19 Pulsar Vascular, Inc. Implantable aneurysm closure systems and methods
US10499927B2 (en) 2005-10-19 2019-12-10 Pulsar Vascular, Inc. Methods and systems for endovascularly clipping and repairing lumen and tissue defects
WO2007140797A1 (en) * 2006-06-02 2007-12-13 Occlutech Gmbh Occlusion instrument for closing a cardiac auricle
US20080221600A1 (en) * 2006-08-17 2008-09-11 Dieck Martin S Isolation devices for the treatment of aneurysms
US9161758B2 (en) * 2007-04-16 2015-10-20 Occlutech Holding Ag Occluder for occluding an atrial appendage and production process therefor
US20120271337A1 (en) * 2007-04-16 2012-10-25 Hans-Reiner Figulla Occluder For Occluding an Atrial Appendage and Production Process Therefor
US9826980B2 (en) * 2007-04-16 2017-11-28 Occlutech Holding Ag Occluder for occluding an atrial appendage and production process therefor
US20160015397A1 (en) * 2007-04-16 2016-01-21 Occlutech Holding Ag Occluder For Occluding An Atrial Appendage And Production Process Therefor
US9023094B2 (en) 2007-06-25 2015-05-05 Microvention, Inc. Self-expanding prosthesis
US8747453B2 (en) 2008-02-18 2014-06-10 Aga Medical Corporation Stent/stent graft for reinforcement of vascular abnormalities and associated method
US8747597B2 (en) 2008-04-21 2014-06-10 Covidien Lp Methods for making braid-ball occlusion devices
US20220022886A1 (en) * 2008-04-21 2022-01-27 Covidien Lp Multiple layer filamentary devices for treatment of vascular defects
US11844528B2 (en) * 2008-04-21 2023-12-19 Covidien Lp Multiple layer filamentary devices for treatment of vascular defects
US8696701B2 (en) 2008-04-21 2014-04-15 Covidien Lp Braid-ball embolic devices
US9585669B2 (en) 2008-04-21 2017-03-07 Covidien Lp Multiple layer filamentary devices for treatment of vascular defects
US8142456B2 (en) 2008-04-21 2012-03-27 Nfocus Neuromedical, Inc. Braid-ball embolic devices
US9039726B2 (en) 2008-04-21 2015-05-26 Covidien Lp Filamentary devices for treatment of vascular defects
US8974487B2 (en) 2008-05-01 2015-03-10 Aneuclose Llc Aneurysm occlusion device
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
US20200100795A1 (en) * 2008-05-01 2020-04-02 Aneuclose Llc "Bowl-of-Spaghetti" Type Intrasacular Aneurysm Occlusion Device
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
US11707371B2 (en) 2008-05-13 2023-07-25 Covidien Lp Braid implant delivery systems
US10610389B2 (en) 2008-05-13 2020-04-07 Covidien Lp Braid implant delivery systems
US9675482B2 (en) 2008-05-13 2017-06-13 Covidien Lp Braid implant delivery systems
US9179918B2 (en) 2008-07-22 2015-11-10 Covidien Lp Vascular remodeling device
US8388650B2 (en) 2008-09-05 2013-03-05 Pulsar Vascular, Inc. Systems and methods for supporting or occluding a physiological opening or cavity
US10285709B2 (en) 2008-09-05 2019-05-14 Pulsar Vascular, Inc. Systems and methods for supporting or occluding a physiological opening or cavity
US11185333B2 (en) 2008-09-05 2021-11-30 Pulsar Vascular, Inc. Systems and methods for supporting or occluding a physiological opening or cavity
US8979893B2 (en) 2008-09-05 2015-03-17 Pulsar Vascular, Inc. Systems and methods for supporting or occluding a physiological opening or cavity
US9615831B2 (en) 2008-09-05 2017-04-11 Pulsar Vascular, Inc. Systems and methods for supporting or occluding a physiological opening or cavity
US8636760B2 (en) 2009-04-20 2014-01-28 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US9277924B2 (en) 2009-09-04 2016-03-08 Pulsar Vascular, Inc. Systems and methods for enclosing an anatomical opening
US11633189B2 (en) 2009-09-04 2023-04-25 Pulsar Vascular, Inc. Systems and methods for enclosing an anatomical opening
US10335153B2 (en) 2009-09-04 2019-07-02 Pulsar Vascular, Inc. Systems and methods for enclosing an anatomical opening
US9095342B2 (en) 2009-11-09 2015-08-04 Covidien Lp Braid ball embolic device features
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
US8906057B2 (en) 2010-01-04 2014-12-09 Aneuclose Llc Aneurysm embolization by rotational accumulation of mass
US8926681B2 (en) 2010-01-28 2015-01-06 Covidien Lp Vascular remodeling device
US9468442B2 (en) 2010-01-28 2016-10-18 Covidien Lp Vascular remodeling device
US8425548B2 (en) 2010-07-01 2013-04-23 Aneaclose LLC Occluding member expansion and then stent expansion for aneurysm treatment
US9610180B2 (en) 2010-12-06 2017-04-04 Covidien Lp Vascular remodeling device
US9351859B2 (en) 2010-12-06 2016-05-31 Covidien Lp Vascular remodeling device
US9393022B2 (en) 2011-02-11 2016-07-19 Covidien Lp Two-stage deployment aneurysm embolization devices
US11147563B2 (en) 2011-03-25 2021-10-19 Covidien Lp Vascular remodeling device
US9089332B2 (en) 2011-03-25 2015-07-28 Covidien Lp Vascular remodeling device
US10004511B2 (en) 2011-03-25 2018-06-26 Covidien Lp Vascular remodeling device
US10959735B2 (en) 2011-03-30 2021-03-30 Noha, Llc Advanced endovascular clip and method of using same
US10028745B2 (en) 2011-03-30 2018-07-24 Noha, Llc Advanced endovascular clip and method of using same
US11284903B2 (en) 2011-03-30 2022-03-29 Hesham Morsi Advanced endovascular clip and method of using same
US9138232B2 (en) 2011-05-24 2015-09-22 Aneuclose Llc Aneurysm occlusion by rotational dispensation of mass
WO2012163880A1 (en) * 2011-05-31 2012-12-06 Acandis Gmbh & Co. Kg Medical implant for arrangement within a hollow body, in particular an aneurysm, and method for producing a medical implant
US11344311B2 (en) 2011-06-03 2022-05-31 Pulsar Vascular, Inc. Aneurysm devices with additional anchoring mechanisms and associated systems and methods
US10624647B2 (en) 2011-06-03 2020-04-21 Pulsar Vascular, Inc. Aneurysm devices with additional anchoring mechanisms and associated systems and methods
US10004510B2 (en) 2011-06-03 2018-06-26 Pulsar Vascular, Inc. Systems and methods for enclosing an anatomical opening, including shock absorbing aneurysm devices
US11654037B2 (en) 2011-09-29 2023-05-23 Covidien Lp Vascular remodeling device
US9060886B2 (en) 2011-09-29 2015-06-23 Covidien Lp Vascular remodeling device
US10828182B2 (en) 2011-09-29 2020-11-10 Covidien Lp Vascular remodeling device
US9119625B2 (en) 2011-10-05 2015-09-01 Pulsar Vascular, Inc. Devices, systems and methods for enclosing an anatomical opening
US10426487B2 (en) 2011-10-05 2019-10-01 Pulsar Vascular, Inc. Devices, systems and methods for enclosing an anatomical opening
US11457923B2 (en) 2011-10-05 2022-10-04 Pulsar Vascular, Inc. Devices, systems and methods for enclosing an anatomical opening
US9636117B2 (en) 2011-10-05 2017-05-02 Pulsar Vascular, Inc. Devices, systems and methods for enclosing an anatomical opening
US10219931B2 (en) * 2011-11-09 2019-03-05 Easynotes Ltd. Obstruction device
US20140350588A1 (en) * 2011-11-09 2014-11-27 Easynotes Ltd. Obstruction device
US9259229B2 (en) 2012-05-10 2016-02-16 Pulsar Vascular, Inc. Systems and methods for enclosing an anatomical opening, including coil-tipped aneurysm devices
US9877856B2 (en) 2012-07-18 2018-01-30 Covidien Lp Methods and apparatus for luminal stenting
US9155647B2 (en) 2012-07-18 2015-10-13 Covidien Lp Methods and apparatus for luminal stenting
US9186267B2 (en) 2012-10-31 2015-11-17 Covidien Lp Wing bifurcation reconstruction device
US9962164B2 (en) 2012-10-31 2018-05-08 Covidien Lp Wing bifurcation reconstruction device
US9924959B2 (en) 2012-11-06 2018-03-27 Covidien Lp Multi-pivot thrombectomy device
US9314248B2 (en) 2012-11-06 2016-04-19 Covidien Lp Multi-pivot thrombectomy device
US11406405B2 (en) 2012-11-06 2022-08-09 Covidien Lp Multi-pivot thrombectomy device
US11786253B2 (en) * 2012-11-13 2023-10-17 Covidien Lp Occlusive devices
US20190343532A1 (en) * 2012-11-13 2019-11-14 Covidien Lp Occlusive devices
US10327781B2 (en) 2012-11-13 2019-06-25 Covidien Lp Occlusive devices
US11690628B2 (en) 2012-11-13 2023-07-04 Covidien Lp Occlusive devices
US9901472B2 (en) 2013-01-17 2018-02-27 Covidien Lp Methods and apparatus for luminal stenting
US9295571B2 (en) 2013-01-17 2016-03-29 Covidien Lp Methods and apparatus for luminal stenting
WO2014128313A1 (en) * 2013-02-21 2014-08-28 Castaño Duque Carlos Device for supporting and positioning occlusive elements
US10716549B2 (en) 2013-03-05 2020-07-21 St. Jude Medical, Cardiology Division, Inc. Medical device for treating a target site
WO2014137467A1 (en) * 2013-03-05 2014-09-12 Aga Medical Corporation Medical device for treating a target site
US20170252045A1 (en) * 2013-03-13 2017-09-07 Lawrence Livermore National Security, Llc Shape-memory polymer foam device for treating aneurysms
US11141164B2 (en) * 2013-03-13 2021-10-12 Lawrence Livermore National Security, Llc Shape-memory polymer foam device for treating aneurysms
US9463105B2 (en) 2013-03-14 2016-10-11 Covidien Lp Methods and apparatus for luminal stenting
US11298144B2 (en) 2013-03-15 2022-04-12 Insera Therapeutics, Inc. Thrombus aspiration facilitation systems
US10335260B2 (en) 2013-03-15 2019-07-02 Insera Therapeutics, Inc. Methods of treating a thrombus in a vein using cyclical aspiration patterns
US10736758B2 (en) 2013-03-15 2020-08-11 Covidien Occlusive device
US10342655B2 (en) 2013-03-15 2019-07-09 Insera Therapeutics, Inc. Methods of treating a thrombus in an artery using cyclical aspiration patterns
US20160213459A1 (en) * 2013-03-15 2016-07-28 Insera Therapeutics, Inc. Vascular treatment devices and methods
US9901435B2 (en) * 2013-03-15 2018-02-27 Insera Therapeutics, Inc. Longitudinally variable vascular treatment devices
US11389309B2 (en) 2013-03-15 2022-07-19 Covidien Lp Occlusive device
US10463468B2 (en) 2013-03-15 2019-11-05 Insera Therapeutics, Inc. Thrombus aspiration with different intensity levels
US10251739B2 (en) 2013-03-15 2019-04-09 Insera Therapeutics, Inc. Thrombus aspiration using an operator-selectable suction pattern
US10751159B2 (en) 2013-07-29 2020-08-25 Insera Therapeutics, Inc. Systems for aspirating thrombus during neurosurgical procedures
US10390926B2 (en) 2013-07-29 2019-08-27 Insera Therapeutics, Inc. Aspiration devices and methods
US11076860B2 (en) 2014-03-31 2021-08-03 DePuy Synthes Products, Inc. Aneurysm occlusion device
US11154302B2 (en) 2014-03-31 2021-10-26 DePuy Synthes Products, Inc. Aneurysm occlusion device
US11389174B2 (en) 2014-04-30 2022-07-19 Cerus Endovascular Limited Occlusion device
WO2015166013A1 (en) 2014-04-30 2015-11-05 Cerus Endovascular Limited Occlusion device
US10130372B2 (en) 2014-04-30 2018-11-20 Cerus Endovascular Limited Occlusion Device
EP3970635A1 (en) 2014-04-30 2022-03-23 Cerus Endovascular Limited Occlusion device
EP3510945A1 (en) 2014-04-30 2019-07-17 Cerus Endovascular Limited Occlusion device
US11284901B2 (en) 2014-04-30 2022-03-29 Cerus Endovascular Limited Occlusion device
CN114391910A (en) * 2014-12-31 2022-04-26 先健科技(深圳)有限公司 Left auricle plugging device
US11883032B2 (en) 2015-02-25 2024-01-30 Galaxy Therapeutics, Inc. System for and method of treating aneurysms
US10856879B2 (en) * 2015-02-25 2020-12-08 Galaxy Therapeutics Inc. System for and method of treating aneurysms
US20180333158A1 (en) * 2015-02-25 2018-11-22 Galaxy Therapeutics, Llc System for and method of treating aneurysms
EP4299019A3 (en) * 2015-04-01 2024-03-06 Boston Scientific Scimed, Inc. Systems for delivery of gel embolics
US10265078B2 (en) 2015-04-01 2019-04-23 Boston Scientific Scimed, Inc. Systems and methods for delivery of gel embolics
WO2016161344A1 (en) * 2015-04-01 2016-10-06 Boston Scientific Scimed, Inc. Systems and methods for delivery of gel embolics
US11877753B2 (en) 2015-04-01 2024-01-23 Boston Scientific Scimed, Inc. Systems and methods for delivery of gel embolics
CN105105812A (en) * 2015-09-18 2015-12-02 王奎重 Intracranial aneurysm interventional embolization treatment device
US11357510B2 (en) 2015-09-23 2022-06-14 Covidien Lp Occlusive devices
US10478194B2 (en) 2015-09-23 2019-11-19 Covidien Lp Occlusive devices
US11471162B2 (en) 2015-12-07 2022-10-18 Cerus Endovascular Limited Occlusion device
EP3782576A1 (en) 2016-03-11 2021-02-24 Cerus Endovascular Limited Occlusion device
US11648013B2 (en) 2016-03-11 2023-05-16 Cerus Endovascular Limited Occlusion device
US10869672B2 (en) 2016-03-11 2020-12-22 Cents Endovascular Limited Occlusion device
WO2017153603A1 (en) 2016-03-11 2017-09-14 Cerus Endovascular Limited Occlusion device
US11484323B2 (en) 2016-05-18 2022-11-01 Microvention, Inc. Embolic containment
US10555738B2 (en) 2016-05-18 2020-02-11 Microvention, Inc. Embolic containment
US10898203B2 (en) 2016-05-18 2021-01-26 Microvention, Inc. Embolic containment
WO2017201316A1 (en) * 2016-05-18 2017-11-23 Microvention, Inc. Embolic containment
CN113180882A (en) * 2016-06-21 2021-07-30 内流医疗有限公司 Device and kit for treating vascular malformed portions
US10751066B2 (en) * 2017-02-23 2020-08-25 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11672543B2 (en) 2017-02-23 2023-06-13 DePuy Synthes Products, Inc. Aneurysm method and system
US20190374232A1 (en) * 2017-02-23 2019-12-12 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US20180242979A1 (en) * 2017-02-23 2018-08-30 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US10743884B2 (en) * 2017-02-23 2020-08-18 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11890020B2 (en) 2017-02-23 2024-02-06 DePuy Synthes Products, Inc. Intrasaccular aneurysm treatment device with varying coatings
US11812971B2 (en) 2017-08-21 2023-11-14 Cerus Endovascular Limited Occlusion device
CN111031938A (en) * 2017-08-22 2020-04-17 柯惠有限合伙公司 Devices, systems, and methods for treating vascular defects
US11185335B2 (en) * 2018-01-19 2021-11-30 Galaxy Therapeutics Inc. System for and method of treating aneurysms
US20190223876A1 (en) * 2018-01-19 2019-07-25 Galaxy Therapeutics, Llc System for and method of treating aneurysms
US10905430B2 (en) 2018-01-24 2021-02-02 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11672540B2 (en) 2018-01-24 2023-06-13 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11596412B2 (en) 2018-05-25 2023-03-07 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11058430B2 (en) * 2018-05-25 2021-07-13 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US10939915B2 (en) 2018-05-31 2021-03-09 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11583288B2 (en) 2018-08-08 2023-02-21 DePuy Synthes Products, Inc. Delivery of embolic braid
US11123077B2 (en) 2018-09-25 2021-09-21 DePuy Synthes Products, Inc. Intrasaccular device positioning and deployment system
US11633191B2 (en) 2018-10-12 2023-04-25 DePuy Synthes Products, Inc. Folded aneurysm treatment device and delivery method
US11076861B2 (en) * 2018-10-12 2021-08-03 DePuy Synthes Products, Inc. Folded aneurysm treatment device and delivery method
US11406392B2 (en) 2018-12-12 2022-08-09 DePuy Synthes Products, Inc. Aneurysm occluding device for use with coagulating agents
US11272939B2 (en) * 2018-12-18 2022-03-15 DePuy Synthes Products, Inc. Intrasaccular flow diverter for treating cerebral aneurysms
US11134953B2 (en) 2019-02-06 2021-10-05 DePuy Synthes Products, Inc. Adhesive cover occluding device for aneurysm treatment
US11337706B2 (en) 2019-03-27 2022-05-24 DePuy Synthes Products, Inc. Aneurysm treatment device
US11497504B2 (en) 2019-05-21 2022-11-15 DePuy Synthes Products, Inc. Aneurysm treatment with pushable implanted braid
US11607226B2 (en) 2019-05-21 2023-03-21 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device with corrugations
US11583282B2 (en) 2019-05-21 2023-02-21 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device
US10653425B1 (en) 2019-05-21 2020-05-19 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device
US11278292B2 (en) 2019-05-21 2022-03-22 DePuy Synthes Products, Inc. Inverting braided aneurysm treatment system and method
US11413046B2 (en) 2019-05-21 2022-08-16 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device
US11672542B2 (en) 2019-05-21 2023-06-13 DePuy Synthes Products, Inc. Aneurysm treatment with pushable ball segment
US11622771B2 (en) 2019-05-25 2023-04-11 Galaxy Therapeutics, Inc. Systems and methods for treating aneurysms
US11166731B2 (en) 2019-05-25 2021-11-09 Galaxy Therapeutics Inc. Systems and methods for treating aneurysms
US10856880B1 (en) 2019-05-25 2020-12-08 Galaxy Therapeutics, Inc. Systems and methods for treating aneurysms
US11202636B2 (en) 2019-05-25 2021-12-21 Galaxy Therapeutics Inc. Systems and methods for treating aneurysms
US11033277B2 (en) 2019-05-25 2021-06-15 Galaxy Therapeutics, Inc. Systems and methods for treating aneurysms
US11058431B2 (en) 2019-05-25 2021-07-13 Galaxy Therapeutics, Inc. Systems and methods for treating aneurysms
US11685007B2 (en) 2019-11-04 2023-06-27 Covidien Lp Devices, systems, and methods for treatment of intracranial aneurysms
US11717924B2 (en) 2019-11-04 2023-08-08 Covidien Lp Devices, systems, and methods for treatment of intracranial aneurysms
US11679458B2 (en) 2019-11-04 2023-06-20 Covidien Lp Devices, systems, and methods for treating aneurysms
US11633818B2 (en) 2019-11-04 2023-04-25 Covidien Lp Devices, systems, and methods for treatment of intracranial aneurysms
US11602350B2 (en) 2019-12-05 2023-03-14 DePuy Synthes Products, Inc. Intrasaccular inverting braid with highly flexible fill material
US11457926B2 (en) 2019-12-18 2022-10-04 DePuy Synthes Products, Inc. Implant having an intrasaccular section and intravascular section
WO2021130064A3 (en) * 2019-12-23 2021-08-19 Phenox Gmbh Implant for treating aneurysms
US11406404B2 (en) 2020-02-20 2022-08-09 Cerus Endovascular Limited Clot removal distal protection methods
CN116687496A (en) * 2023-08-04 2023-09-05 北京久事神康医疗科技有限公司 Plug device with net disc

Also Published As

Publication number Publication date
CA2481224A1 (en) 2003-10-23
US9314326B2 (en) 2016-04-19
ATE439092T1 (en) 2009-08-15
US20070106311A1 (en) 2007-05-10
WO2003086240A1 (en) 2003-10-23
US20110196413A1 (en) 2011-08-11
DE60328765D1 (en) 2009-09-24
CA2481224C (en) 2010-12-21
EP1494619B1 (en) 2009-08-12
EP1494619A1 (en) 2005-01-12
JP4414767B2 (en) 2010-02-10
JP2005522266A (en) 2005-07-28
AU2003224913A1 (en) 2003-10-27
ES2331567T3 (en) 2010-01-08

Similar Documents

Publication Publication Date Title
US9314326B2 (en) System and method for retaining vaso-occlusive devices within an aneurysm
US11076860B2 (en) Aneurysm occlusion device
US20200000477A1 (en) Embolization Plug
US6036720A (en) Sheet metal aneurysm neck bridge
EP1109499B1 (en) Detachable aneurysm neck closure patch
US11154302B2 (en) Aneurysm occlusion device
US6193708B1 (en) Detachable aneurysm neck bridge (I)
JP6719963B2 (en) Inflatable vasoocclusive device with leadframe coil
US20170035430A1 (en) Devices and Methods for Treatment of Endovascular and Non-Endovascular Defects in Humans Using Occlusion Implants
EP3622901A1 (en) Aneurysm occlusion device
US20180317933A1 (en) Devices and Methods for Treatment of Endovascular and Non-Endovascular Defects in Humans
JPH1071154A (en) Aneurysm closure device assembly
JP2003524433A (en) Quickly detachable electrically insulated implant
US20180221030A1 (en) Devices and Methods for Treatment of Endovascular and Non-Endovascular Defects in Humans Using Tandem Embolization Devices
KR102359744B1 (en) Vascular Implantation System and Vascular Implantation Process Using Flexible Separation Area
CN115670566A (en) Related systems and methods for vessel occlusion
WO2020139544A2 (en) Shape adaptable multi-layered intra-saccular flow reduction device and methods of manufacturing same
WO2024035592A1 (en) Delivery devices for treatment of vascular defects

Legal Events

Date Code Title Description
AS Assignment

Owner name: TARGET THERAPEUTICS, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WALLACE, MICHAEL;EDER, JOSEPH;GERBERDING, BRENT;REEL/FRAME:012812/0175

Effective date: 20020411

AS Assignment

Owner name: BOSTON SCIENTIFIC SCIMED, INC. (FORMERLY SCIMED LI

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE PREVIOUSLY RECORDED ON REEL 012812 FRAME 0175;ASSIGNORS:WALLACE, MICHAEL;EDER, JOSEPH;GERBERDING, BRENT;REEL/FRAME:018863/0279

Effective date: 20020411

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: STRYKER NV OPERATIONS LIMITED, IRELAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOSTON SCIENTIFIC SCIMED, INC.;REEL/FRAME:026162/0967

Effective date: 20110103

Owner name: STRYKER CORPORATION, MICHIGAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOSTON SCIENTIFIC SCIMED, INC.;REEL/FRAME:026162/0967

Effective date: 20110103

AS Assignment

Owner name: STRYKER MEDTECH LIMITED, MALTA

Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:STRYKER NV OPERATIONS LIMITED;REEL/FRAME:037153/0034

Effective date: 20151013

Owner name: STRYKER EUROPEAN HOLDINGS I, LLC, MICHIGAN

Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:STRYKER MEDTECH LIMITED;REEL/FRAME:037153/0241

Effective date: 20151013

AS Assignment

Owner name: STRYKER CORPORATION, MICHIGAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOSTON SCIENTIFIC SCIMED, INC.;REEL/FRAME:037156/0607

Effective date: 20110103

Owner name: STRYKER NV OPERATIONS LIMITED, IRELAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOSTON SCIENTIFIC SCIMED, INC.;REEL/FRAME:037156/0607

Effective date: 20110103

AS Assignment

Owner name: STRYKER EUROPEAN HOLDINGS I, LLC, MICHIGAN

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT LISTED SERIAL NOS. 09/905,670 AND 07/092,079 PREVIOUSLY RECORDED AT REEL: 037153 FRAME: 0241. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE DATE 9/29/2014;ASSIGNOR:STRYKER MEDTECH LIMITED;REEL/FRAME:038043/0011

Effective date: 20151013

Owner name: STRYKER MEDTECH LIMITED, MALTA

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT SERIAL # 09/905,670 AND 07/092,079 PREVIOUSLY RECORDED AT REEL: 037153 FRAME: 0034. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:STRYKER NV OPERATIONS LIMITED;REEL/FRAME:038039/0001

Effective date: 20151013

AS Assignment

Owner name: STRYKER EUROPEAN OPERATIONS HOLDINGS LLC, MICHIGAN

Free format text: CHANGE OF NAME;ASSIGNOR:STRYKER EUROPEAN HOLDINGS III, LLC;REEL/FRAME:052860/0716

Effective date: 20190226

Owner name: STRYKER EUROPEAN HOLDINGS III, LLC, DELAWARE

Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:STRYKER EUROPEAN HOLDINGS I, LLC;REEL/FRAME:052861/0001

Effective date: 20200519